CodeSystem |
https://ncez.mzcr.cz/fhir/CodeSystem/snomed-supplement-service-type | SNOMED CT Supplement typu registrujícího poskytovatele |
https://smartforms.csiro.au/ig/CodeSystem/HealthChecksSCTSupplement | SNOMED CT Supplement for Aboriginal and Torres Strait Islander Health Check |
https://demis.rki.de/fhir/CodeSystem/translationEvidence | Übersetzung Symptom und Manifestation |
https://www.medizininformatik-initiative.de/fhir/core/modul-diagnose/CodeSystem/mii-cs-diagnose-lebensphase-supplement-snomed | MII_CS_Diagnose_Lebensphase_Supplement_SNOMED |
http://hl7.org/fhir/us/davinci-hrex/ConceptMap/CareTeamMember-NUCCFunction | SNOMED Care Team Member Function to NUCC Map |
http://hl7.org/fhir/us/davinci-hrex/ConceptMap/NUCC-CareTeamMemberFunction | NUCC to SNOMED Care Team Member Function Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/CertifierTypesCM | CertifierTypes Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/ContributoryTobaccoUseCM | ContributoryTobaccoUse Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/MannerOfDeathCM | MannerOfDeath Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/MethodOfDispositionCM | MethodOfDisposition Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/PlaceOfDeathCM | PlaceOfDeath Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/TransportationIncidentRoleCM | TransportationIncidentRole Concept Map |
http://fhir.ch/ig/ch-term/ConceptMap/DocumentEntryClassCodeToDocumentEntryTypeCode | DocumentEntryClassCodeToDocumentEntryTypeCode |
http://fhir.ch/ig/ch-term/ConceptMap/HCProfessionalHCProfessionSpecialisationMap | HCProfessionalHCProfessionSpecialisationMap |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-targetdiseases-vaccines-cm | TargetDisease To VaccineCode Mapping |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sct-sm-cm | Snomed CT VaccineCode To SwissMedic VaccineCode |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sct-targetdiseases-cm | Snomed CT VaccineCode To TargetDisease Mapping |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sm-sct-cm | SwissMedic VaccineCode To Snomed CT VaccineCode |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-targetdiseases-cm | VaccineCode To TargetDisease Mapping |
http://fhir.ch/ig/ch-core/ConceptMap/documententry-confidentialitycode-to-fhir | DocumentEntry.confidentialityCode to FHIR mapping |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapBirthAttendantTitlesVitalRecords | BirthAttendantTitles Concept Map |
http://hl7.org/fhir/us/mcode/ConceptMap/TG263CM | TG263 Concept Map |
http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-to-foph-patient-name-representation | CH ELM Results To FOPH Patient Name Representation |
http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-to-interpretation-code | CH ELM Results To Interpretation Code |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-do-missing-measurement | Activitydefinition-code to do missing measurement |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-do-reminder | Activitydefinition-code to do reminder |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-measurement-resource-type | Activitydefinition-code to measurement resource type |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-perform-sharing | Activitydefinition-code-to-perform-sharing |
http://ehealth.sundhed.dk/ConceptMap/conceptmap-device-type-to-medcom-device-type | Device type to MedCom device type |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyIntoleranceCategory | CCDA to FHIR Allergy Intolerance Category |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyIntoleranceType | CCDA to FHIR Allergy Intolerance Type |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyStatus | C-CDA to FHIR Allergy Status |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-NoKnownAllergies | C-CDA to FHIR No Known Allergies |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-ProblemStatus | C-CDA Problem Status value to FHIR Condition clinicalStatus |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-Severity | C-CDA Severity to FHIR Severity |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyIntoleranceCategory | FHIR to CCDA Allergy Intolerance Category |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyIntoleranceType | FHIR Allergy Intolerance Type to CCDA value |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyStatus | FHIR to C-CDA Allergy Status |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-ImmunizationRefusal | FHIR Immunization Status Reason to C-CDA Immunization Refusal |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-ImmunizationSite | FHIR Immunization Site to C-CDA Immunization approachSiteCode |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-NoKnownAllergies | FHIR to C-CDA No Known Allergies |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-ProblemStatus | FHIR Condition clinicalStatus to C-CDA Problem Status value |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-Severity | FHIR Severity to C-CDA Severity |
http://smart.who.int/ddcc/ConceptMap/lab-test-pathogen-snomed-to-icd11 | Lab Test - Result - Pathogen - Mapping SNOMED CT to ICD-11 |
http://smart.who.int/ddcc/ConceptMap/lab-test-qual-result-snomed-to-icd11 | Lab Test - Result - Mapping SNOMED CT to ICD-11 |
http://smart.who.int/ddcc/ConceptMap/vaccine-covid19-snomed-to-icd11 | Vaccine - COVID-19 - Mapping SNOMED to ICD-11 |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-agent-targeted | ConceptMap from ICD-11 to SNOMED CT for Agent Targeted |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-disease-targeted | ConceptMap from ICD-11 to SNOMED CT for Disease or Agent Targeted |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-test-result | ConceptMap from ICD-11 to SNOMED CT for Test Result |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-vaccines | ConceptMap from ICD-11 to SNOMED CT for Vaccines |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-ichi-sct-specimen-origin | ConceptMap from ICHI to SNOMED CT for Specimen Origin |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-ichi-sct-type-of-test | ConceptMap from ICHI to SNOMED CT for Type of Test |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-loinc-sct-type-of-test | ConceptMap from LOINC to SNOMED CT for Type of Test |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-sct-ichi-specimen-origin | ConceptMap from SNOMED CT to ICHI for Specimen Origin |
http://hl7.org/fhir/us/davinci-alerts/ConceptMap/direct-alerts | Direct ADT to Da Vinci Alerts ConceptMap |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/health-professional-tw | 臺灣醫事司醫事人員類別代碼對應SNOMED CT及臺灣醫事司醫事人員類別 |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medical-consultation-department-nhi-tw | 臺灣健保署就醫科別代碼對應SNOMED CT |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medical-treatment-department-nhi-tw | 臺灣健保署診療科別代碼對應SNOMED CT |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medication-path-tw | 臺灣健保署給藥途徑代碼對應SNOMED CT |
http://hl7.org/fhir/us/bfdr/ConceptMap/BirthAttendantTitlesCM | BirthAttendantTitles Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/BirthDeliveryOccurredCM | BirthDeliveryOccurred Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/DeliveryRoutesCM | DeliveryRoutes Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalDeathCauseOrConditionCM | FetalDeathCauseOrCondition Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalDeathTimePointsCM | FetalDeathTimePoints Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalPresentationCM | FetalPresentation Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/InfectionsDuringPregnancyLiveBirthCM | InfectionsDuringPregnancyLiveBirth Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/NewbornCongenitalAnomaliesCM | NewbornCongenitalAnomalies Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/PerformedNotPerformedPlannedCM | PerformedNotPerformedPlanned Concept Map |
http://moh.gov.et/fhir/hiv/ConceptMap/LOINCCodesToSNOMED | ConceptMap to and from LOINC to SNOMED |
http://moh.gov.et/fhir/hiv/ConceptMap/SNOMEDCodesToProprietary | ConceptMap to and from SNOMED to Proprietary |
http://hl7.nl/fhir/zorgviewer/ConceptMap/epic-rolcode | Epic Provider Type naar SNOMED-CT Mapping |
http://smart.who.int/immunizations-measles/ConceptMap/IMMZConceptsToSNOMED | ConceptMap to and from SNOMED |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_DPE_Declaration_Type_German | Art der Erklärung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Implant_German | Medizinprodukt |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Person_Institution_German | BAI_ART |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Procedure_German | Prozedur SNOMEDCT |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Reaction_Allergy_German | Allergie Manifestation |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Runaway_Risk_German | Weglaufgefährdung |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Terminology_Complete_German | KBV_CM_Base_Terminology_Complete_German |
http://fhir.tasmc.org.il/ConceptMap/tasmc-snomedct-specimen-type | tasmc Specimen Type Concept map |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_AB0_System_First_Examination_After_Childbirth_German | KBV_CM_MIO_MR_AB0_System_First_Examination_After_Childbirth_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_AB0_System_German | KBV_CM_MIO_MR_AB0_System_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Biometrics_II_III_German | KBV_CM_MIO_MR_Biometrics_II_III_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Biometrics_I_German | KBV_CM_MIO_MR_Biometrics_I_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Birth_Mode_German | KBV_CM_MIO_MR_Birth_Mode_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Breastfeeding_Behavior_German | KBV_CM_MIO_MR_Breastfeeding_Behavior_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Catalogue_A_German | KBV_CM_MIO_MR_Catalogue_A_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Child_Position_German | KBV_CM_MIO_MR_Child_Position_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Counselling_German | KBV_CM_MIO_MR_Counselling_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Direct_Coombstest_German | KBV_CM_MIO_MR_Direct_Coombstest_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Interpretation_German | KBV_CM_MIO_MR_Examination_Interpretation_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Result_Qualitative_German | KBV_CM_MIO_MR_Examination_Result_Qualitative_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Snomed_German | KBV_CM_MIO_MR_Examination_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Findings_Required_Control_German | KBV_CM_MIO_MR_Findings_Required_Control_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_General_Information_German | KBV_CM_MIO_MR_General_Information_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Heart_Sounds_Child_German | KBV_CM_MIO_MR_Heart_Sounds_Child_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Immunization_Status_German | KBV_CM_MIO_MR_Immunization_Status_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Localisation_Placenta_German | KBV_CM_MIO_MR_Localisation_Placenta_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Morphology_German | KBV_CM_MIO_MR_Morphology_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Other_Ultrasound_Studies_German | KBV_CM_MIO_MR_Other_Ultrasound_Studies_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Practitioner_Function_German | KBV_CM_MIO_MR_Practitioner_Function_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Pregnancy_Information_German | KBV_CM_MIO_MR_Pregnancy_Information_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Rhesus_System_German | KBV_CM_MIO_MR_Rhesus_System_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Special_Findings_German | KBV_CM_MIO_MR_Special_Findings_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_oGTT_Diagnosistest_German | KBV_CM_MIO_MR_oGTT_Diagnosistest_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_oGTT_Pretest_German | KBV_CM_MIO_MR_oGTT_Pretest_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_LAB_ELGA_Specimen_Type_SNOMED_German | ELGA Probenart SNOMED |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_IHEXDS_AuthorSpeciality_Restricted_German | KBV_CM_MIO_Vaccination_IHEXDS_AuthorSpeciality_Restricted_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_Titer_Immunity_German | Titer Immunität |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Prior_Disease_German | VaccinationrelevantDisease |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Prior_Disease_Snomed_ICD | KBV_CM_MIO_Vaccination_Prior_Disease_Snomed_ICD |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Source_of_Information_German | Source_of_Information |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_ATC_Snomed | KBV_CM_MIO_Vaccination_Vaccine_ATC_Snomed |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_German | Vaccine |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_Targetdisease | KBV_CM_MIO_Vaccination_Vaccine_Targetdisease |
http://nictiz.nl/fhir/ConceptMap/Alcoholgebruik-to-AlcoholGebruikStatusCodelijst | Alcoholgebruik-to-AlcoholGebruikStatusCodelijst |
http://nictiz.nl/fhir/ConceptMap/Rookgedrag-to-TabakGebruikStatusCodelijst | Rookgedrag-to-TabakGebruikStatusCodelijst |
http://nictiz.nl/fhir/ConceptMap/WerkelijkePlaatsBaring-to-ActEncounterCode | WerkelijkePlaatsBaring-to-ActEncounterCode |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Rhesus_System_Fetus_German | Rhesus-System des Fötus |
https://fhir.ee/ConceptMap/person-relationship-mpi-v3 | Mapping of MPI person relationship to legacy V3 |
https://fhir.ee/ConceptMap/person-relationship-v3-mpi | Mapping of legacy V3 person relationship to MPI |
https://demis.rki.de/fhir/ConceptMap/LOINCMaterialToSNOMEDMaterial | LOINCMaterialToSNOMEDMaterial |
https://demis.rki.de/fhir/ConceptMap/LOINCMethodToSNOMEDMethod | LOINCMethodToSNOMEDMethod |
http://nictiz.nl/fhir/ConceptMap/AllergieCategorieCodelijst-to-AllergyIntoleranceCategory | AllergieCategorieCodelijst to AllergyIntoleranceCategory |
http://nictiz.nl/fhir/ConceptMap/ErnstCodelijst-to-AllergyIntoleranceSeverity | ErnstCodelijst to AllergyIntoleranceSeverity |
http://nictiz.nl/fhir/ConceptMap/InterpretatieVlaggenCodelijst-to-ObservationInterpretationCodes | InterpretatieVlaggenCodelijst to ObservationInterpretationCodes |
http://nictiz.nl/fhir/ConceptMap/MateVanKritiekZijnCodelijst-to-AllergyIntoleranceCriticality | MateVanKritiekZijnCodelijst to AllergyIntoleranceCriticality |
http://nictiz.nl/fhir/ConceptMap/ProbleemStatusCodelijst-to-ConditionClinicalStatusCodes | ProbleemStatusCodelijst to ConditionClinicalStatusCodes |
http://nictiz.nl/fhir/ConceptMap/VerificatieStatusCodelijst-to-ConditionVerificationStatus | VerificatieStatusCodelijst to ConditionVerificationStatus |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_ULB_Overview | KBV_CM_MIO_ULB_Overview |
http://ig.ehealth4u.eu/fhir/ConceptMap/cyehr-cm-allergyreactionseverity-snomed2hl7fhir | Cyprus EHR Concept Map: Allergy Reaction Severity - Snomed to HL7 FHIR |
http://ig.ehealth4u.eu/fhir/ConceptMap/cyehr-cm-allergytype-snomed2hl7fhir | Cyprus EHR Concept Map: Allergy Type - Snomed to HL7 FHIR |
https://fhir.nhs.uk/STU3/ConceptMap/CareConnect-AllergySeverity-1 | Concept Map - Allergy Severity |
https://fhir.nhs.uk/STU3/ConceptMap/CareConnect-AllergyVerificationStatus-1 | Concept Map - Allergy Verification Status |
https://hl7chile.cl/fhir/ig/gravitycl/ValueSet/SDOHCC-ValueSetLOINCSNOMEDCT-CL | ValueSet SDOHCC LOINC-SNOMEDCT |
https://fhir-ig.digital.health.nz/screening/ValueSet/nz-screening-programmetype-code | Codes for categorization of NZ types of screening programme |
https://ranzcr.com/fhir/ValueSet/radiology-referral | RANZCR Radiology Referral |
http://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType | eHDSI Adverse Event Type |
http://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug | eHDSI Allergen No Drug |
http://terminology.ehdsi.eu/ValueSet/eHDSIAnimalSpecies | eHDSI Animal Species |
http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup | eHDSI Blood Group |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite | eHDSI Body Site |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodySiteLaterality | eHDSI Body Site Laterality |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodyStructureLocation | eHDSI Body Structure Location Qualifier |
http://terminology.ehdsi.eu/ValueSet/eHDSICodeProb | eHDSI Code Prob |
http://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus | eHDSI Current Pregnancy Status |
http://terminology.ehdsi.eu/ValueSet/eHDSILabSpecimenType | eHDSI Laboratory Specimen Type |
http://terminology.ehdsi.eu/ValueSet/eHDSILabTechnique | eHDSI Laboratory Technique |
http://terminology.ehdsi.eu/ValueSet/eHDSIMedicalDevice | eHDSI Medical Device |
http://terminology.ehdsi.eu/ValueSet/eHDSIMicroorganism | eHDSI Microorganism |
http://terminology.ehdsi.eu/ValueSet/eHDSIMorphologicAbnormality | eHDSI Morphologic Abnormality |
http://terminology.ehdsi.eu/ValueSet/eHDSIOutcomeOfPregnancy | eHDSI Outcome of Pregnancy |
http://terminology.ehdsi.eu/ValueSet/eHDSIPresenceAbsence | eHDSI Presence Absence |
http://terminology.ehdsi.eu/ValueSet/eHDSIProcedure | eHDSI Procedure |
http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy | eHDSI Reaction Allergy |
http://terminology.ehdsi.eu/ValueSet/eHDSIResolutionOutcome | eHDSI Resolution Outcome |
http://terminology.ehdsi.eu/ValueSet/eHDSISeverity | eHDSI Severity |
http://terminology.ehdsi.eu/ValueSet/eHDSISocialHistory | eHDSI Social History |
http://terminology.ehdsi.eu/ValueSet/eHDSIStatusCode | eHDSI Status Code |
http://terminology.ehdsi.eu/ValueSet/eHDSIVaccine | eHDSI Vaccine |
http://hl7.org/fhir/uv/lab-report/ValueSet/laterality-uv-lab | Body Structure Laterality |
http://hl7.org/fhir/uv/lab-report/ValueSet/siteQualifier-uv-lab | Body Structure Qualifier |
http://hl7.org/fhir/uv/lab-report/ValueSet/specialty-uv-lab | Laboratory Specialty |
http://hl7.org/fhir/uv/lab-report/ValueSet/speciesType-uv-lab | Types of species |
http://hl7.org/fhir/uv/lab-report/ValueSet/specimenAdditive-uv-lab | Specimen Additive |
http://hl7.org/fhir/uv/lab-report/ValueSet/specimenContainer-uv-lab | Specimen Container |
http://hl7.org/fhir/uv/lab-report/ValueSet/specimenType-uv-lab | Specimen Types |
http://hl7.org/fhir/uv/lab-report/ValueSet/technique-uv-lab | Laboratory Techniques |
http://hl7.org/cda/us/eyecare/ValueSet/AidToVisionCodes | Aid to Vision Codes |
http://hl7.org/cda/us/eyecare/ValueSet/DiagnosticAssessmentEyeTestCodes | Diagnostic Assessment Eye Test Value Set |
http://hl7.org/cda/us/eyecare/ValueSet/EyecareTargetSiteCodes | Eyecare Target Site Codes |
http://hl7.org/cda/us/eyecare/ValueSet/PosteriorSegmentObservationCodes | Posterior Segment Observation Codes |
http://hl7.org/cda/us/eyecare/ValueSet/PosteriorSegmentOrganizerCodes | Posterior Segment Organizer Codes |
http://hl7.org/cda/us/eyecare/ValueSet/RefractionMethodCodes | Refraction Method Codes |
http://hl7.org/cda/us/eyecare/ValueSet/RefractionObservationCodes | Refraction Observation Codes |
http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityMethodCodes | Visual Acuity Method Codes |
http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityObservationCodes | Visual Acuity Observation Codes |
http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityOrganizerCodes | Visual Acuity Organizer Codes |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-bodysite | Body Site |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-laterality | Laterality |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-reaction-manifestation-code | Reaction Manifestation Code |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-score | Score Value Set |
https://fhir.infoway-inforoute.ca/ValueSet/encountertype | Encounter Type |
https://fhir.infoway-inforoute.ca/ValueSet/ethnicitycode | EthnicityCode |
http://fhir.hie.moh.gov.my/ValueSet/adverse-event-event-my-core | ValueSetAdverseEventEvent (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/allergy-manifestation-my-core | value-set-allergy-manifestation-my-core |
http://fhir.hie.moh.gov.my/ValueSet/allergy-negation-my-core | ValueSetAllergyNegation (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/child-identification-type-my-core | ValueSetChildIdentificationType (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/dev-milestone-my-core | ValueSetDevMilestone (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/glucose-level-my-core | ValueSetGlucoseLevel(MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/observation-glucose-my-core | ValueSetObservationGlucose (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/observation-social-history-my-core | ValueSetObservationSocialHistory (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/procedure-category-my-core | ValueSetProcedureCategory (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/procedure-code-my-core | ValueSetProcedureCode (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/side-my-core | ValueSetSide (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/site-my-core | ValueSetSite (MY Core) |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-contributing-factor-vs | AdverseEvent Contributing Factor |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-mitigating-action-vs | AdverseEvent Mitigating Action |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-supporting-info | AdverseEvent Supporting Information |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-type-vs | AdverseEvent Type |
https://www.ehealth.fgov.be/standards/fhir/medication/ValueSet/medication-exposure-category-vs | Medication exposure intent |
http://hl7.org/fhir/uv/shc-vaccination/ValueSet/lab-result-findings | Lab result findings (SNOMED CT) |
http://hl7.org/fhir/uv/shc-vaccination/ValueSet/specimen-collection-supervision-status | Specimen Collection Supervision Status |
https://profiles.ihe.net/ITI/Scheduling/ValueSet/sct-services | IHE ITI Scheduling Snomed CT Services |
https://profiles.ihe.net/ITI/Scheduling/ValueSet/specialty | IHE ITI Scheduling Specialties |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-certifier-types-vs | Certifier Types Value Set |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-contributory-tobacco-use-vs | Contributory Tobacco Use ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-death-certification-event-max-vs | Event Code for Death Certificate Composition - Max |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-death-certification-event-vs | Event Code for Death Certificate Composition |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-manner-of-death-vs | Manner of Death ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-method-of-disposition-vs | Method of Disposition ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-place-of-death-vs | Place of Death ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-transportation-incident-role-vs | Transportation Incident Role ValueSet |
https://hl7chile.cl/fhir/ig/clcore/ValueSet/VSDiagnosticosSCT | Diagnósticos SNOMED y Ausente o Desconocido |
http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-consentstatus | Consent Status |
http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-legalrelation | Legal Relation |
http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-personalrelation | Personal Relation |
http://jembi.org/fhir/ValueSet/key-population-status-value-set | Key Population Status Value Set |
https://nzhts.digital.health.nz/fhir/ValueSet/vaping-status | Vaping Status |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-allergic-disposition-sct | Allergic Disposition SCT |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-assessment-scales | Assessment Scales |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-assessment | Assessment |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-body-positioning-snomed | Body Positioning SNOMED CT |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-drugs | Drugs |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-observations | Observations |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-procedures | Procedures |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-radiologic-finding-sct | Radiologic Finding SCT |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-substances-snomed | Substances SNOMED CT |
http://fhir.ch/ig/ch-term/ValueSet/ActivePharmaceuticalIngredient | ActivePharmaceuticalIngredient |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceConditionValueSet | CH AllergyIntolerance Condition |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceReactionManifestationValueSet | CH AllergyIntolerance Reaction Manifestation |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceReactionSubstanceValueSet | CH AllergyIntolerance Reaction Substance |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceValueSet | CH AllergyIntolerance |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.classCode | DocumentEntry.classCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.confidentialityCode | DocumentEntry.confidentialityCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.healthcareFacilityTypeCode | DocumentEntry.healthcareFacilityTypeCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.practiceSettingCode | DocumentEntry.practiceSettingCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.typeCode | DocumentEntry.typeCode |
http://fhir.ch/ig/ch-term/ValueSet/HCProfessional.hcProfession | HCProfessional.hcProfession |
http://fhir.ch/ig/ch-term/ValueSet/SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode |
http://fhir.ch/ig/ch-term/ValueSet/UnitCode | UnitCode |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-ch-vaccination-plan-immunizations-vs | CH VACD Swiss Vaccination Plan Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-recommendation-categories-vs | CH VACD Recommendation Categories for Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs | CH VACD Target disease and illnesses undergone for immunization |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-vaccines-snomedct-vs | CH VACD Snomed CT for vaccine code |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-vaccines-vs | CH VACD Swissmedic code for vaccine code |
http://hl7.org/fhir/uv/cqm/ValueSet/chronic-liver-disease-legacy-example | Chronic Liver Disease Legacy Example |
https://build.fhir.org/ig/ReMeDi-Blut/remedi_ig/ValueSet/blood-products-value-set | BloodProductsValueSet |
http://fhir.ch/ig/ch-lab-order/ValueSet/MicrobiolProcedures | Microbiological Procedure |
http://fhir.ch/ig/ch-lab-order/ValueSet/clinical-focus-vitamin-d | Vitamin D all possible clinical contexts for test |
http://fhir.ch/ig/ch-lab-order/ValueSet/normal-contexts-vitamin-d | Contexts for reimbursement of the vitamin D test |
http://fhir.ch/ig/ch-lab-order/ValueSet/reasons-for-order | All Valid Reasons for Ordering a Lab Service |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-immunization-allergyintolerances-vs | Allergies and Intolerance values for Immunization |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-medical-vs | Swiss Medical Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-occupation-vs | Swiss Occupation Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-preillness-vs | Swiss Preillness Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-social-vs | Swiss Social Risks For Immunizations |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-birth-attendant-titles-vr | Value Set - Birth Attendants Titles Vital Records |
http://hl7.org/fhir/uv/livd/ValueSet/resultvalue-mappings-livd | Result value mappings value set for LIVD |
http://bloodpressure.oemig.de/fhir/ValueSet/BodyPosition | Body Position |
https://fhir.virtually.healthcare/ValueSet/SmokingStatus | SmokingStatus |
https://fhir-ig.digital.health.nz/rheumatic-fever/ValueSet/nz-questionnaireresponse-qualifiedyesno-code | Generic QuestionnaireResponse yes/no question answer codes |
https://fhir-ig.digital.health.nz/rheumatic-fever/ValueSet/rf-careteam-participant-role-code | Rheumatic fever patient care team participant role codes |
https://fhir-ig.digital.health.nz/rheumatic-fever/ValueSet/rf-condition-diagnosis-code | Codes for summary diagnosis of the rheumatic fever condition |
https://fhir-ig.digital.health.nz/rheumatic-fever/ValueSet/rf-condition-rhdseverity-code | Rheumatic heart disease severity codes |
https://fhir-ig.digital.health.nz/rheumatic-fever/ValueSet/rf-condition-symptomaticatdiagnosis-code | Codes for rheumatic heart disease symptom status at time of diagnosis |
https://fhir-ig.digital.health.nz/rheumatic-fever/ValueSet/rf-medicationallergy-code | Rheumatic fever medication allergy codes |
https://fhir-ig.digital.health.nz/rheumatic-fever/ValueSet/rf-medicationrequest-frequency-code | Rheumatic fever planned medication frequency codes |
https://fhir-ig.digital.health.nz/rheumatic-fever/ValueSet/rf-observation-diagnosis-component-code | Codes for component observations of NZ rheumatic fever diagnosis |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-benign-uncertain-neoplasm-brain-cns-disorder-vs | Benign Neoplasm of Brain and CNS Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-body-location-and-laterality-qualifier-vs | Body Location and Laterality Qualifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-high-dose-rate-electronic-technique-vs | Brachytherapy High Dose Rate Electronic Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-high-dose-rate-technique-vs | Brachytherapy High Dose Rate Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-low-dose-rate-temporary-technique-vs | Brachytherapy Low Dose Rate Temporary Radiation Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-modality-vs | Brachytherapy Modality Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-permanent-seeds-technique-vs | Brachytherapy Permanent Seeds Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-pulsed-dose-rate-technique-vs | Brachytherapy Pulsed Dose Rate Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-radiopharmaceutical-technique-vs | Brachytherapy Radiopharmaceutical Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-breslow-depth-stage-value-vs | Breslow Depth Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-body-location-vs | Cancer Body Location Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-disease-status-evidence-type-vs | Cancer Disease Status Evidence Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-related-surgical-procedure-vs | Cancer-Related Surgical Procedure Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-stage-type-vs | Cancer Stage Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-stage-value-vs | Cancer Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-method-vs | Cancer Staging Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-prognostic-factor-type-vs | Cancer Staging Prognostic Factors Types |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-prognostic-factor-value-vs | Cancer Staging Prognostic Factors Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-carcinoma-in-situ-disorder-vs | Carcinoma In-Situ Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-clark-level-value-vs | Clark Level Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-clin-or-path-modifier-vs | Clinical or Pathologic Modifier |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-condition-status-trend-max-vs | Condition Status Trend Maximum Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-condition-status-trend-vs | Condition Status Trend Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cytologic-evidence-malignancy-vs | Cytologic Evidence of Malignancy Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-fab-classification-value-vs | FAB Classification Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-figo-staging-method-vs | FIGO Staging Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-gleason-grade-group-value-vs | Gleason Grade Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-histologic-grade-vs | Histologic Grade Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-histologic-grading-system-vs | Histologic Grading System Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-histology-morphology-behavior-vs | Histology Morphology Behavior Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-history-of-metastatic-malignant-neoplasm-vs | History of Metastatic Malignant Neoplasm Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-hypereosinophilic-syndrome-disorder-vs | Specific Diagnosis of Cancer Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-laterality-qualifier-vs | Laterality Qualifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-stage-bulky-modifier-vs | Lymphoma Stage Bulky Modifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-stage-value-modifier-vs | Lymphoma Stage Value Modifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-stage-value-vs | Lymphoma Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-staging-method-vs | Lymphoma Staging System Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-melanoma-in-situ-disorder-vs | Melanoma In-Situ Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-neuroblastoma-inss-value-vs | International Neuroblastoma Staging System (INSS) for Neuroblastoma Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-normalization-basis-vs | Normalization Basis Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-primary-malignant-neoplasm-disorder-vs | Primary Malignant Neoplasm Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-procedure-intent-vs | Procedure Intent Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-radiotherapy-treatment-location-qualifier-vs | Radiotherapy Treatment Location Qualifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-radiotherapy-treatment-location-vs | Radiotherapy Treatment Location Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-radiotherapy-volume-type-vs | Radiotherapy Volume Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-rai-staging-method-vs | Rai Staging System Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-rhabdomyosarcoma-assessment-value-vs | Rhabdomyosarcoma Assessment Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-rhabdomyosarcoma-clinical-group-value-vs | Rhabdomyosarcoma Clinical Group Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-risk-assessment-vs | Risk Assessment Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-secondary-cancer-disorder-vs | Secondary Cancer Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-carbon-ion-beam-technique-vs | Carbon Ion Beam Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-electron-beam-technique-vs | Electron Beam Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-modality-vs | Teleradiotherapy Modality Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-neutron-beam-technique-vs | Neutron Beam Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-photon-beam-technique-vs | Photon Beam Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-proton-beam-technique-vs | Proton Beam Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-distant-metastases-category-vs | TNM Distant Metastases Category Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-distant-metastases-staging-type-vs | TNM Distant Metastases Staging Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-primary-tumor-category-vs | TNM Primary Tumor Category Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-primary-tumor-staging-type-vs | TNM Primary Tumor Staging Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-regional-nodes-category-vs | TNM Regional Nodes Category Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-regional-nodes-staging-type-vs | TNM Regional Nodes Staging Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-stage-group-staging-type-vs | TNM Stage Group Staging Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-stage-group-vs | TNM Stage Group Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-staging-method-vs | TNM Staging Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-treatment-termination-reason-vs | Treatment Termination Reason Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tumor-morphology-code-max-vs | Tumor Morphology Code Max Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tumor-morphology-code-vs | Tumor Morphology Code Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tumor-size-method-vs | Tumor Size Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-wilms-tumor-body-site-vsCOG | Wilms Tumor Body Site Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-wilms-tumor-stage-value-vs | Wilms Tumor Stage Value Set |
http://terminology.hl7.org/uv/eyecare/ValueSet/body-site-eye | Ophthalmic anatomical location |
http://terminology.hl7.org/uv/eyecare/ValueSet/conditions | Ophthalmology Condition ICD10 and SNOMED codes ValueSet |
http://terminology.hl7.org/uv/eyecare/ValueSet/iop-methods | Intraocular pressure (IOP) method valueset |
http://terminology.hl7.org/uv/eyecare/ValueSet/observable-entities | Ophthalmology observations (SNOMED) |
http://terminology.hl7.org/uv/eyecare/ValueSet/observation-visual-acuity-methods | Visual acuity chart valueset (SNOMED) |
http://terminology.hl7.org/uv/eyecare/ValueSet/observation-visual-acuity | Visual acuity method valueset (SNOMED) |
http://terminology.hl7.org/uv/eyecare/ValueSet/observation-visual-field | Visual Field Observable Entities ValueSet |
http://terminology.hl7.org/uv/eyecare/ValueSet/procedures | Ophthalmology Procedures Valueset |
http://terminology.hl7.org/uv/eyecare/ValueSet/qualifiers | Ophthalmic anatomical location qualifiers |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/TNM-M-clinical-category-vs | Clinical M |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/TNM-M-pathologycal-category-vs | Pathological M |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/TNM-N-clinical-category-vs | Clinical N |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/TNM-N-pathological-category-vs | Pathological N |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/TNM-T-clinical-category-vs | Clinical T |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/TNM-T-pathological-category-vs | Pathological T |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/admission-voluntary-status-vs | Encounter Voluntary Status Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/allergy-intolerance-substances-xpandh-vs | AllergyIntoleranceSubstancesXpandhVS |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/anthropometric-observation-vs | Anthropometric Observation Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/bmi-observation-vs | BMI Observation Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/body-height-observation-vs | Body Height Observation Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/body-weight-observation-vs | Body Weight Observation Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/cancer-stage-grading-vs | Cancer Stage Grading: Snomed CT |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/cancer-stageGroup-vs | Cancer Stage Group: SNOMED CT |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/circumference-observation-vs | Circumference Observation Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/functional-assessment-scales-vs | Xpandh Functional Assessment Scales |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/hdr-condition-mandatory-xpandh-vs | Mandatory Condition Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/hdr-condition-xpandh-vs | Condition Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/hdr-encounter-type-xpandh-vs | In-patient Encounter Type Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/hdr-treated-xpandh-vs | Treatment Class Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/medical-devices-xpandh-vs | Medical Devices (SNOMED CT) - Xpandh |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/procedure-snomed-xpandh-vs | Procedure codes: Snomed CT |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/skinfold-thickness-vs | Skinfold Thickness Value Set |
http://hl7.eu/fhir/ig/xpandh/hdr/ValueSet/vital-signs-observation-vs | Vital Signs Observation Value Set |
http://fhir.org/guides/acme/HotBeverage/ValueSet/NoDecaf | Decaf is for the weak |
http://hl7.org/fhir/uv/order-catalog/ValueSet/example-clinical-focus | All possible clinical contexts for any lab test |
http://hl7.org/fhir/uv/order-catalog/ValueSet/example-normal-contexts-vitamin-d | Contextes de remboursement du dosage de la vitamine D |
http://hl7.org/fhir/uv/order-catalog/ValueSet/example-reasons-for-order | All Valid Reasons for Ordering a Lab Service |
http://hl7.eu/fhir/ig/flute/ValueSet/VS-BiopsyType | Type of Biopsy |
http://hl7.eu/fhir/ig/flute/ValueSet/VS-DREOutcomeCode | DRE Observation Interpretation Codes |
http://hl7.eu/fhir/ig/flute/ValueSet/VS-PCa | Malignant tumor of prostate Value Set |
http://hl7.org/fhir/uv/vulcan-rwd/ValueSet/ExampleDialysisProcedureCodes | Diabetes Example Dialysis Test Codes |
http://hl7.org/fhir/uv/vulcan-rwd/ValueSet/ExampleRespiratoryConditionCodes | Covid-19 Example Condition Codes |
https://IntelliSOFT-Consulting.github.io/HIV-FHIR-IG/ValueSet/OnARV | History of antiretroviral therapy (situation) |
http://hl7.org/fhir/ValueSet/adverse-event-type | AdverseEvent Type |
http://hl7.org/fhir/us/covid19library/ValueSet/pregnancy-status-value-set | Pregnancy Status Value Set |
https://ncez.mzcr.cz/fhir/ValueSet/typ-registrujiciho-lekare-vs | Typ registrujícího lékaře / Type of registering physician |
http://hl7.eu/fhir/eps/ValueSet/medical-devices-eu-hdr | Medical Devices (SNOMED CT) - Xpandh |
http://hl7.org/fhir/us/vitals/ValueSet/BodyTempAssociatedSituationVS | Body Temperature Associated Situation value set |
http://hl7.org/fhir/us/vitals/ValueSet/BodyWeightAssociatedSituationVS | Associated Situation value set |
http://hl7.org/fhir/us/vitals/ValueSet/MeasSettingVS | Measurement Setting value set |
http://hl7.org/fhir/us/vitals/ValueSet/bodyPositionVS | Body Position value set |
http://hl7.org/fhir/us/vitals/ValueSet/bodyTempMeasBodyLocationPrecoordVS | Body Temperature Measurement Body Location value set |
http://hl7.org/fhir/us/vitals/ValueSet/bodyTempMeasurementDeviceVS | Body Temperature Measurement Device value set |
http://hl7.org/fhir/us/vitals/ValueSet/bpCuffSizeVS | Blood Pressure Cuff Size value set |
http://hl7.org/fhir/us/vitals/ValueSet/bpMeasDeviceVS | Blood Pressure Measurement Device value set |
http://hl7.org/fhir/us/vitals/ValueSet/bpMeasMethodVS | Blood Pressure Measurement Method value set |
http://hl7.org/fhir/us/vitals/ValueSet/bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoordinated value set |
http://hl7.org/fhir/us/vitals/ValueSet/definedLimitsVS | Defined Limits value set |
http://hl7.org/fhir/us/vitals/ValueSet/exertionPhaseVS | Exertion Phase value set |
http://hl7.org/fhir/us/vitals/ValueSet/heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set |
http://hl7.org/fhir/us/vitals/ValueSet/heartRateMeasDeviceVS | Heart Rate Measurement Device value set |
http://hl7.org/fhir/us/vitals/ValueSet/heartRateMeasMethodVS | Heart Rate Measurement Method value set |
http://hl7.org/fhir/us/vitals/ValueSet/heightBodyPositionVS | Height Body Position value set |
http://hl7.org/fhir/us/vitals/ValueSet/heightLengthMeasDeviceVS | Height Length Measurement Device value set |
http://hl7.org/fhir/us/vitals/ValueSet/heightLengthMeasMethodVS | Height Length Measurement Method value set |
http://hl7.org/fhir/us/vitals/ValueSet/respiratoryRateMeasDeviceVS | Respiratory Rate Measurement Device value set |
http://hl7.org/fhir/us/vitals/ValueSet/respiratoryRateMeasMethodVS | Respiratory Rate Measurement Method value set |
http://hl7.org/fhir/us/vitals/ValueSet/sPO2BodyLocationVS | Oxygen Saturation Body Location value set |
http://hl7.org/fhir/us/vitals/ValueSet/sensorDescriptionVS | Sensor Description value set |
http://hl7.org/fhir/us/vitals/ValueSet/sleepStatusVS | Sleep Status value set |
http://hl7.org/fhir/us/vitals/ValueSet/weightMeasurementDeviceVS | Weight Measurement Device value set |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-interpretation-codes-avidity | CH ELM Interpretation Codes AVIDITY |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-interpretation-codes-sero | CH ELM Interpretation Codes SERO |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-bru-org | CH ELM Results Bru Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-camp-diar-org | CH ELM Results Camp Diar Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-camp-org | CH ELM Results Camp Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-chol-org | CH ELM Results Chol Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-cjd-org | CH ELM Results Cjd Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-coded-values-laboratory | CH ELM Results Coded Values Laboratory |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-complete-spec | CH ELM Results Complete Spec |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-cpe-org | CH ELM Results Cpe Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-diph-org | CH ELM Results Diph Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-geni-spec | CH ELM Results Geni Spec |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-haem-org | CH ELM Results Haem Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-hanta-org | CH ELM Results Hanta Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-influenza-hxny-org | CH ELM Results Influenza Hxny Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-laboratory-observation | CH ELM Results Laboratory Observation |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-leg-org | CH ELM Results Leg Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-lis-org | CH ELM Results Lis Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-mal-org | CH ELM Results Mal Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-maldi-tof-org | CH ELM Results Maldi-tof Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-mea-org | CH ELM Results Mea Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-men-org | CH ELM Results Men Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-pneu-org | CH ELM Results Pneu Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-sal-org-complete | CH ELM Results Sal Org Complete |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-sal-org | CH ELM Results Sal Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-shi-org | CH ELM Results Shi Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-sterile-spec | CH ELM Results Sterile Spec |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-tul-org | CH ELM Results Tul Org |
http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-virus-cult-org | CH ELM Results Virus Cult Org |
https://smartforms.csiro.au/ig/ValueSet/CervicalScreeningStatus-1 | Cervical Screening Status |
https://smartforms.csiro.au/ig/ValueSet/SmokingQuitStatus-1 | Smoking Quit Status |
https://smartforms.csiro.au/ig/ValueSet/TobaccoUseStatus-1 | Tobacco Use Status |
https://healthterminologies.gov.au/fhir/ValueSet/biological-sex-1 | Biological Sex |
https://healthterminologies.gov.au/fhir/ValueSet/clinical-condition-1 | Clinical Condition |
https://healthterminologies.gov.au/fhir/ValueSet/gender-identity-response-1 | Gender Identity Response |
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-Hx-UGIB-snomed | Upper gastrointestinal bleed Value Set |
https://profiles.ihe.net/PCC/APS/ValueSet/Advance.Directives.VS | Advance Directives |
https://profiles.ihe.net/PCC/APS/ValueSet/Antepartum.Education.VS | Antepartum Education |
https://profiles.ihe.net/PCC/APS/ValueSet/Antepartum.Family.History.and.Genetic.Screening.VS | Antepartum Family History and Genetic Screening |
https://profiles.ihe.net/PCC/APS/ValueSet/Antepartum.History.of.Infection.VS | Antepartum History of Infection |
https://profiles.ihe.net/PCC/APS/ValueSet/Antepartum.History.of.Past.Illness.VS | Antepartum History of Past Illness |
https://profiles.ihe.net/PCC/APS/ValueSet/Antepartum.Review.of.Systems.Menstrual.History.VS | Antepartum Review of Systems Menstrual History |
https://profiles.ihe.net/PCC/APS/ValueSet/Smoking.Status.VS | Smoking Status |
http://hl7.org/fhir/us/physical-activity/ValueSet/pa-diagnosticreport-category | PA ServiceRequest Category - USCore |
http://hl7.org/fhir/us/physical-activity/ValueSet/pa-servicerequest-code | PA ServiceRequest Intervention Codes |
http://hl7.org/fhir/uv/phr/ValueSet/pcd-sleep-observation-code | Patient contributed data: sleep observation code |
http://hl7.org/fhir/uv/phr/ValueSet/pcd-sleep-observation-value | Patient contributed data: sleep stage value |
http://terminology.hl7.org.au/ValueSet/amt-mp-codes | AMT Medicinal Product and Substances |
http://terminology.hl7.org.au/ValueSet/rsg-type | AU Recorded Sex or Gender Type |
https://paho.org/fhir/esavi/ValueSet/CodigoMedicamentoVS | Codigo Medicamento |
https://paho.org/fhir/esavi/ValueSet/CodigoNoWhoVacunaVS | Código no WHODrug de la Vacuna |
https://paho.org/fhir/esavi/ValueSet/ComplicacionEmbarazoOtroVS | Otros Códigos Complicaciones en Embarazo ESAVI |
https://paho.org/fhir/esavi/ValueSet/EnfermedadesPreviasCodificacionVS | Enfermedades previas en un ESAVI-PAHO |
https://paho.org/fhir/esavi/ValueSet/EsaviOtroVS | Otros Códigos Evento Adverso |
https://paho.org/fhir/esavi/ValueSet/FormaFarmaceuticaVS | Identificación Formas Farmacéuticas |
https://paho.org/fhir/esavi/ValueSet/ViaAdminMedicamentoVS | Vías de Administración de Medicamentos |
http://fhir.kl.dk/term/ValueSet/KLComplicationCodesSCT | KLKomplikationskoderSCT |
http://fhir.kl.dk/term/ValueSet/KLEvaluationTypeCodesSCT | KLVurderingTypekoderSCT |
http://fhir.kl.dk/term/ValueSet/KLObservationCodes | KLObservationskoder |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/alcoholUsageStatus-snomed-eu-i4rc | Alcohol Usage Status: SNOMED CT |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/comorbidities-sct-eu-i4rc | Comorbidities: SNOMED |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/hypopharynx-subsite-sct-i4rc | Hypopharynx subsite: Snomed CT |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/larynx-subsite-sct-i4rc | Larynx subsite: Snomed CT |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/lip-subsite-sct-i4rc | Lip subsite: Snomed CT |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/nasal-paranasal-subsite-sct-i4rc | Nasal cavity and paranasal sinuses subsite: Snomed CT |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/nasopharynx-subsite-sct-i4rc | Nasopharynx subsite: Snomed CT |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/oralCavity-subsite-sct-i4rc | Oral cavity subsite: Snomed CT |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/oropharynx-subsite-sct-i4rc | Oropharynx subsite: Snomed CT |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/siteRare-i4rc | Site rare (IDEA4RC) |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/vs-calcest-eu-i4rc | Calculated|Estimated |
https://euvabeco.net/vcds-ig/ValueSet/HealthProfession | Health professions |
http://sundhedsdatastyrelsen.dk/terminologi/dk-ihe-healthcarefacilitytypecode-vs | DK_IHE_HealthcareFacilityTypeCode_VS |
http://sundhedsdatastyrelsen.dk/terminologi/dk-ihe-practicesettingcode-vs | DK_IHE_practiceSettingCode_VS |
http://ehealth.sundhed.dk/vs/activitydefinition-code | Activity Definition Code |
http://ehealth.sundhed.dk/vs/clinicalimpression-finding-codes | ClinicalImpression Finding Codes |
http://ehealth.sundhed.dk/vs/clinicalimpression-investigation-item-codes | ClinicalImpression Investigation Item Codes |
http://ehealth.sundhed.dk/vs/device-types | Device Types |
http://ehealth.sundhed.dk/vs/document-class | Document Class |
http://ehealth.sundhed.dk/vs/facility-type-codes | Facility Type Codes |
http://ehealth.sundhed.dk/vs/questionnaire-types | Questionnaire Types |
http://ehealth.sundhed.dk/vs/sor-organization-type | SorOrganizationType |
http://ehealth.sundhed.dk/vs/sor-organization-specialty | SorOrganizationSpecialty |
https://www.hl7.it/fhir/terminology/ValueSet/additivo-campione-it | Additivo Campione |
https://www.hl7.it/fhir/terminology/ValueSet/campione-container-lab-it | Container Campione |
https://www.hl7.it/fhir/terminology/ValueSet/results-microorganism-snomed-ct-ips-free-set | Risultato osservazione codificato - microorganismo IPS di SNOMED CT |
https://www.hl7.it/fhir/terminology/ValueSet/results-observation-bloodgroup | Risultato osservazione codificato - Gruppo Sanguigno IPS di SNOMED CT |
https://www.hl7.it/fhir/terminology/ValueSet/results-presence-absence-snomed-ct-ips-free-set | Risultato osservazione codificato - presenza/assenza IPS di SNOMED CT |
https://www.hl7.it/fhir/terminology/ValueSet/tipo-campione-lab-it | Tipo campione |
https://www.hl7.it/fhir/terminology/ValueSet/valueset-observation-value-bloodgroup | Risultato osservazione codificato gruppo sanguigno |
https://www.hl7.it/fhir/terminology/ValueSet/valueset-observation-value-microorganism | Risultato osservazione codificato microorganismi |
https://www.hl7.it/fhir/terminology/ValueSet/valueset-observation-value-presence-absence | Risultato osservazione codificato presenza/assenza |
http://canshare.co.nz/fhir/ValueSet/an-dose-adjustment-reason-vs | Dose adjustment reason |
http://canshare.co.nz/fhir/ValueSet/an-dx-basis-vs | Basis of diagnosis |
http://canshare.co.nz/fhir/ValueSet/an-ecog-status-vs | ECOG status |
http://canshare.co.nz/fhir/ValueSet/an-er-status-vs | ER status |
http://canshare.co.nz/fhir/ValueSet/an-regimen-discontinued-patient-factors-vs | Patient factors when discontinuing a regimen |
http://canshare.co.nz/fhir/ValueSet/an-regimen-discontinued-toxicity-vs | Toxicity reasons why a regimen was discontinued |
http://canshare.co.nz/fhir/ValueSet/an-regimen-iot-vs | Intent of treatment |
http://canshare.co.nz/fhir/ValueSet/an-her2-status-vs | HER2 status |
http://canshare.co.nz/fhir/ValueSet/an-pr-status-vs | ER status |
http://canshare.co.nz/fhir/ValueSet/an-recurrence-type-vs | Type of recurrence |
http://terminology.hl7.org/ValueSet/device-kind | FHIR Device Types |
http://terminology.hl7.org/ValueSet/edible-substance-type | Types of Edible Substances |
http://terminology.hl7.org/ValueSet/gender-identity | Gender Identity |
http://terminology.hl7.org/ValueSet/snomed-intl-gps | SNOMED International Global Patient Set (GPS) |
http://terminology.hl7.org/ValueSet/v3-AllergyStatus | Allergy Status |
http://terminology.hl7.org/ValueSet/v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue |
http://terminology.hl7.org/ValueSet/v3-KnowledgeSubtopicObservationValue | KnowledgeSubtopicObservationValue |
http://terminology.hl7.org/ValueSet/v3-ObservationMeasureCountableItems | ObservationMeasureCountableItems |
http://terminology.hl7.org/ValueSet/v3-immunizationForecastStatusObservationValue | immunizationForecastStatusObservationValue |
http://hl7.org/fhir/us/davinci-ra/ValueSet/confidence-scale | Confidence Scale Value Set |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/AxillaSurgeryVS | Axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationImpactVS | Impact of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationTypeVS | Type of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EducationLevelVS | Education level of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EstrogenStatusVS | Estrogen receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GermlineMutationVS | Germline Mutation ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GradingVS | Grading of tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HER2ReceptorStatusVS | HER2 receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HistologicalTypeVS | Histological type of the tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityNewCancerVS | Laterality of new cancer ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityVS | Laterality of breast cancer ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LocationRadiotherapyVS | The location of radiotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/MenopausalStatusVS | Menopausal status of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/PatientTreatPrefVS | Patient treatment preference ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ProgesteroneStatusVS | Progesterone receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecommendedTreatmentTypeVS | Recommended treatment types ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecurrenceMethodVS | Recurrence method ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationReasonVS | Reasoncode of the re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationTypeVS | Type of re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedTherapyVS | Type of targeted therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TherapyIntentVS | Intent of therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TreatmentTypeVS | Type of treatments ValueSet |
http://hl7.org/fhir/us/dental-data-exchange/ValueSet/dental-observation-codes | Dental Observation Codes |
http://hl7.org/fhir/us/dental-data-exchange/ValueSet/dental-reason-for-referral | DentalReasonForReferral |
http://hl7.org/fhir/us/dental-data-exchange/ValueSet/oral-cavity-area | Oral Cavity Area |
http://hl7.org/fhir/us/dental-data-exchange/ValueSet/tooth-identification-valueset | Tooth Identification ValueSet |
http://hl7.pt/fhir/core/ValueSet/snomed-ct-vs | Snomed Value Set |
http://medcomfhir.dk/ig/terminology/ValueSet/medcom-conditionlist-status-valueset | MedComConditionListStatus |
http://hl7.org/fhir/uv/emedicinal-product-info/ValueSet/routeOfAdministration | Route Of Administration |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Active.Advance.Directive.Finding.VS | Active Advanced Healthcare Directives Findings Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Airbag.Type.VS | Airbag Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Airway.Device.Confirmation.Method.VS | Airway Device Confirmation Method Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Airway.Device.Type.VS | Airway Device Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Barrier.To.Care.VS | Barrier To Care Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Blood.Pressure.Measurement.Method.VS | Blood Pressure Measurement Method Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Arrest.Etiology.VS | Cardiac Arrest Etiology Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Arrest.Outcome.VS | Cardiac Arrest Outcome Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Arrest.Witness.Role.VS | Cardiac Arrest Witness Role Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Rhythm.Reading.VS | Cardiac Rhythm Readings Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiopulmonary.Resuscitation.Type.VS | Cardiopulmonary Resuscitation Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/ChiefComplaint.Anatomic.Location.VS | ChiefComplaint Anatomic Location Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/ChiefComplaint.Organ.System.VS | ChiefComplaint Organ System Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Collision.Object.VS | Collision Object Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Complication.Subset.VS | Complication Subset Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Destination.Prearrival.Activation.Type.VS | Destination Prearrival Activation Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Device.Type.VS | ECG Device Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Disaster.Type.VS | Disaster Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/IHE.PCC.APGAR.VS | IHE PCC mPSC APGAR Assessment Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/IHE.PCC.Facility.Ward.VS | IHE PCC mPSC Facility Ward Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Length.Based.Weight.Class.VS | Length Based Weight Class Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Level.Of.Responsiveness.AVPU.VS | Level Of Responsiveness AVPU Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Location.In.Vehicle.VS | Location In Vehicle Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Mechanism.Of.Injury.VS | Mechanism Of Injury Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Medication.Administration.Device.VS | Medication Administration Device Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Medication.Complication.VS | Medication Complication Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/PSC.Location.Type.VS | PSC Location Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Emergency.Event.Sub.List.VS | Paramedicine Emergency Event Sub List Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Observation.Interpretation.VS | Paramedicine Observation Interpretation Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Physical.Findings.of.Nervous.System.VS | Physical Finding of Nervous System Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Physical.Findings.of.Respiratory.System.VS | Physical Finding of Respiratory System Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Provider.Roles.VS | Paramedicine Provider Roles Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Reason.For.Visit.VS | Paramedicine Reason For Visit Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Vehicle.Type.VS | Paramedicine Vehicle Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Pathient.Transfer.to.Ambulance.Method.VS | Pathient Transfer to Ambulance_Method Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Abdomen.TargetSite.VS | Physical Finding of Abdomen Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Abdomen.VS | Physical Finding of Abdomen Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.TargetSite.VS | Physical Finding of Back Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.VS | Physical Finding of Back Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.and.Spine.VS | Physical Finding of Back and Spine Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Chest.TargetSite.VS | Physical Finding of Chest Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Chest.VS | Physical Finding of Chest Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Extremities.TargetSite.VS | Physical Finding of Extremities Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Extremities.VS | Physical Finding of Extremities Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Eye.TargetSite.VS | Physical Finding of Eye Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Eye.VS | Physical Finding of Eye Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Face.VS | Physical Finding of Face Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.GenitourinaryTract.VS | Physical Finding of Genitourinary Tract Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Head.VS | Physical Finding of Head Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Heart.VS | Physical Finding of Heart Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Lung.TargetSite.VS | Physical Finding of Lung Tartget Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Lung.VS | Physical Finding of Lung Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Neck.VS | Physical Finding of Neck Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pelvis.VS | Physical Finding of Pelvis Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pelvis.and.Genitourinary.VS | Physical Finding of Pelvis and Genitourinary Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pupil.TargetSite.VS | Physical Finding of Back and Spine Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pupil.VS | Physical Finding of Pupil Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Skin.VS | Physical Finding of Skin Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Spine.TargetSite.VS | Physical Finding of Spine Spine Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Protective.Equipment.VS | Protective Equipment Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Pulse.Rhythm.VS | Pulse Rhythm Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Reason.For.Visit.VS | Reason For Visit Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Respiratory.Effort.VS | Respiratory Effort Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Response.VS | Paramedicine Treatment Response Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Safety.Equipment.VS | Safety Equipment Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Stroke.Assessment.Interpretation.VS | Stroke Assessment Interpretation Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Stroke.Scale.Type.VS | Stroke Scale Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Substance.Use.Evidence.VS | Substance Use Evidence Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Transport.Method.VS | Transport Method Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Vehicle.Type.VS | Vehicle Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Weight.Estimation.Tape.Values.VS | Physical Finding of Pelvis and Genitourinary Value Set |
http://hl7.org/fhir/us/sdoh-clinicalcare/ValueSet/SDOHCC-ValueSetLOINCSNOMEDCT | SDOHCC ValueSet LOINC SNOMEDCT |
http://hl7.org/fhir/uv/sdc/ValueSet/species | Questionnaire Context Species |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-uv-ips | Allergy Intolerance - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-reaction-uv-ips | Allergy Reaction - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/body-site-uv-ips | Body Site - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/current-smoking-status-uv-ips | Current Smoking Status - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medical-devices-uv-ips | Medical Devices - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medication-example-uv-ips | Medications - example (IPS) |
http://hl7.org/fhir/uv/ips/ValueSet/medication-uv-ips | Medications - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medicine-active-substances-uv-ips | Medicine Active Substances - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/pregnancy-status-uv-ips | Pregnancy Status - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/problems-uv-ips | Problems - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/procedures-uv-ips | Procedures - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-coded-values-laboratory-pathology-uv-ips | Results Coded Values Laboratory/Pathology - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-numobs-uv-ips | Results Radiology Measurement Observation - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-txtobs-uv-ips | Results Radiology Textual Observation - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-collection-method-uv-ips | Results Specimen Collection Method - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-type-uv-ips | Results Specimen Type - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/target-diseases-uv-ips | Vaccine Target Diseases - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/vaccines-uv-ips | Vaccines - IPS |
http://hl7.org/fhir/us/pacio-adi/ValueSet/ADIDocumentationTypeVS | Documentation Types |
http://fhir.ch/ig/ch-epreg/ValueSet/ch-ig-example-sct | CH IG Example SNOMED CT |
http://hl7.org/fhir/uv/phenomics-exchange/ValueSet/Onset | Onset ValueSet |
http://fhir.health.gov.lk/ips/ValueSet/vs-follow-up-plan | Follow-up plan |
http://fhir.health.gov.lk/ips/ValueSet/vs-medical-conditions | Conditions |
http://fhir.health.gov.lk/ips/ValueSet/vs-reason-for-encounter | Reason For Encounter |
http://fhir.health.gov.lk/ips/ValueSet/vs-risk-behaviour-physical-activity | Physical Activity |
http://smart.who.int/ddcc/ValueSet/LabTestPathogenCovid19SnomedValueSet | Lab Test - Pathogen - COVID-19 - SNOMED CT |
http://smart.who.int/ddcc/ValueSet/LabTestQualitativeResultSnomedValueSet | Lab Test - Qualitative Result - SNOMED CT |
http://smart.who.int/ddcc/ValueSet/VaccineCovid19SnomedValueSet | Vaccine - COVID-19 - SNOMED CT |
http://hl7.eu/fhir/laboratory/ValueSet/lab-laterality-eu-lab | Body Structure Laterality |
http://hl7.eu/fhir/laboratory/ValueSet/lab-siteQualifier-eu-lab | Body Structure Qualifier |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specialty-eu-lab | Laboratory Specialty |
http://hl7.eu/fhir/laboratory/ValueSet/lab-speciesType-eu-vs | Types of species |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenAdditive-eu-lab | Specimen Additive |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenContainer-eu-lab | Specimen Container |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenType-eu-lab | Specimen Types |
http://hl7.eu/fhir/laboratory/ValueSet/lab-technique-eu-lab | Laboratory Techniques |
http://hl7.org/fhir/us/central-cancer-registry-reporting/ValueSet/cancer-core-reportability-codes | Cancer Core Reportability Codes |
http://interopsante.org/fhir/ValueSet/fr-medicinal-product-only | French Medicinal Product only |
http://interopsante.org/fhir/ValueSet/fr-method-of-administration | French Method Of Administration |
http://interopsante.org/fhir/ValueSet/fr-mp-dose-form | French Medicinal product Dose form |
http://interopsante.org/fhir/ValueSet/fr-mp-substance-active | French Medicinal product Active substance |
http://interopsante.org/fhir/ValueSet/fr-mp-unit-of-presentation | French Medicinal product Unit of Presentation |
http://interopsante.org/fhir/ValueSet/fr-route-of-administration | French Route of Administration |
http://interopsante.org/fhir/ValueSet/fr-treatment-intent | French overall intention of the treatment |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-diabetes | CVDRA Diabetes |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-percutaneous-coronary-intervention | CVDRA Percutaneous Coronary Intervention |
https://nzhts.digital.health.nz/fhir/ValueSet/Smoking-status-code | Smoking status |
https://nzhts.digital.health.nz/ns/ValueSet/health-service-type-refset-vs | Health service type refset vs |
https://nzhts.digital.health.nz/fhir/ValueSet/air-status-reason-code | AIR status reason code |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-coronary-artery-bypass-grafting | CVDRA Coronary Artery Bypass Grafting |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-transient-ischaemic-attack | CVDRA Transient Ischaemic Attack (TIA) |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-fh-premature-ischaemic-cvd | CVDRA Family History Of Premature Ischaemic CVD |
https://nzhts.digital.health.nz/fhir/ValueSet/air-route-of-administration | AIR route of administration |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-peripheral-vascular-disease | CVDRA Peripheral Vascular Disease |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-renal-failure | CVDRA Renal Failure |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-smoking-status | CVDRA Smoking Status |
https://nzhts.digital.health.nz/ValueSet/cvdra-heart-failure | CVDRA Heart failure |
https://nzhts.digital.health.nz/fhir/ValueSet/rheumatic-fever-care-team-participant-role | Rheumatic fever care team participant role |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-ischaemic-stroke | CVDRA Ischaemic Stroke |
https://nzhts.digital.health.nz/fhir/ValueSet/air-disease-covered-code | AIR diseases covered code |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-AJCC-residual-tumour | NZ AJCC latest edition residual tumour category clinical |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-AJCC8-residual-tumour-clincal | NZ AJCC 8th edition residual tumour category clinical |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-AJCC8-residual-tumour | NZ AJCC (8th edition) edition residual tumour category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-acute-leukaemia-cancer-type | NZ cancer acute leukaemia cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-adrenal-topography | NZ cancer adrenal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ajcc-staging-chapter | NZ AJCC staging chapter |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ajcc-staging-manual-edition | NZ AJCC cancer staging manual edition |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ann-arbor-lymphoma-stage | NZ cancer Ann Arbor lymphoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-agressive-cancer-type | NZ cancer aggressive B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-agressive-nhl-cancer-type | NZ cancer aggressive non-Hodgkin B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-indolent-cancer-type | NZ cancer indolent B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-indolent-nhl-cancer-type | NZ cancer indolent non-Hodgkin B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-lymphoid-cancer-type | NZ cancer B cell lymphoid cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-lymphoid-substream | NZ cancer B cell lymphoid substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-lymphoma-cancer-type | NZ cancer B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-basis-of-cancer-diagnosis | NZ cancer basis of diagnosis |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bl-ipi-prognostic-score | NZ cancer BL-IPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-cancer-type | NZ cancer bone cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-other-topography | NZ cancer bone other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-pelvis-topography | NZ cancer bone pelvis topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-thoracic-topography | NZ cancer bone thoracic topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-vertebral-column-topography | NZ cancer bone vertebral column topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-ancillary-studies | NZ cancer breast ancillary studies |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-clinical-behaviour-category | NZ cancer breast clinical behaviour category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-clinical-presentation | NZ cancer breast clinical presentation |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-mammogram-finding | NZ cancer breast mammogram finding |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-non-nac-topography | NZ cancer breast non-nipple-areola complex topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-procedure-image-guided-method | NZ cancer breast procedure image guided method |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-radiology-type | NZ cancer breast radiology type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-related-topography | NZ cancer breast related topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-specimen-resection-procedure-type | NZ cancer breast resection procedure type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-ultrasound-finding | NZ cancer breast ultrasound finding |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-colorectal-topography-resection | NZ cancer gastrointestinal colorectal resection topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-colorectal-topography-subtype-metastectomy | NZ cancer colorectal metastectomy topography subtype |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-laboratory-test-method | NZ cancer laboratory test method |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-ngs-pcr | NZ cancer PCR OR NGS test method |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-procedure-specimen-gi-cr-diagnostic | NZ cancer gastrointestinal diagnostic specimen collection procedure |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-procedure-specimen-gi-cr-resection-met | NZ cancer gastrointestinal colorectal metastecomy resection specimen collection procedure |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-procedure-specimen-gi | NZ cancer gastrointestinal specimen collection procedure |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-service | NZ cancer service |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-stream | NZ cancer stream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-topography-colonoscopy | NZ cancer colonoscopy topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-clinical-impression-behaviour | NZ cancer clinical impression of behaviour |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-clinical-scale | NZ cancer clinical assessment scale |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-clockface-position | NZ cancer clockface position |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-brain-topography | NZ cancer central nervous system brain topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-cancer-type | NZ cancer CNS cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-ipi-prognostic-score | NZ cancer CNS-IPI for large B cell lymphoma prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-meninges-topography | NZ cancer central nervous system meninges topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-nerve-topography | NZ cancer central nervous system nerve topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-other-topography | NZ cancer central nervous system other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-status-prognostic-score | NZ cancer CNS status in acute lymphoblastic leukaemia lymphoma prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-topography | NZ cancer central nervous system topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-cancer-type | NZ cancer colorectal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-colon-perforation | NZ perforation present in colon |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-obstruction-perforation | NZ colorectal obstruction or perforation present in colon |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-obstruction | NZ colorectal obstruction present |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-perforation | NZ colorectal perforation present |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-referral-criteria-surveillance | NZ cancer colorectal surveillance colonoscopy referral criteria |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-data-absent-reason | NZ cancer data absent reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-diagnosis-clinical-status | NZ cancer diagnosis clinical status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-document-type | NZ cancer document type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eln-prognostic-score | NZ cancer ELN standardised reporting for genetic alteration in AML prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-neuroendocrine-cancer-type | NZ cancer endocrine and neuroendocrine cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-neuroendocrine-substream | NZ cancer endocrine and neuroendocrine substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-neuroendocrine-topography | NZ cancer endocrine and/or neuroendocrine topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-other-topography | NZ cancer endocrine other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-topography | NZ cancer endocrine topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-er-expression | NZ cancer ER expression |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eutos-prognostic-score | NZ cancer EUTOS for CML prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-excision-specimen-type | NZ cancer excision specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-cancer-type | NZ cancer eye and orbit cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-lacrimal-drainage-system-topography | NZ cancer eye and orbit lacrimal drainage system topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-lacrimal-gland-topography | NZ cancer eye and orbit lacrimal gland topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-optic-nerve-topography | NZ cancer eye and orbit optic nerve topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-other-topography | NZ cancer eye and orbit other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-uveal-tract-topography | NZ cancer eye and orbit uveal tract topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-cervix-uteri-topography | NZ cancer female genital cervix uteri topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-corpus-uteri-topography | NZ cancer female genital corpus uteri topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-fallopian-tube-topography | NZ cancer female genital fallopian tube topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-gestational-trophoblastic-topography | NZ cancer female genital gestational trophoblastic disease topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-peritoneum-topography | NZ cancer female genital peritoneum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-uterine-ligament-topography | NZ cancer female genital uterine ligament topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-vulva-topography | NZ cancer female genital vulva topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2001-gestational-stage | NZ cancer FIGO 2001 gestational trophoblastic disease stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2009-endometrial-carcinoma-stage | NZ cancer FIGO 2009 endometrial carcinoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2015-corpus-uteri-adenosarcoma-stage | NZ cancer FIGO 2015 corpus uteri adenosarcoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2018-cervix-uteri-stage | NZ cancer FIGO 2018 cervix uteri stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2021-vulva-stage | NZ cancer FIGO 2021 vulva stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-flipi-prognostic-score | NZ cancer FLIPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-follicular-lymphoma-grade | NZ cancer follicular lymphoma grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-frozen-section-specimen-type | NZ cancer frozen section specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gastro-cancer-type | NZ cancer gastrointestinal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gastro-substream | NZ cancer gastrointestinal substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-genitourinary-substream | NZ cancer genitourinary substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-anus-topography | NZ cancer gastroenteropancreatic neuroendocrine tumour anal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-appendix-topography | NZ cancer gastroenteropancreatic neuroendocrine tumour appendix topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-colorectal-topography | NZ cancer gastroenteropancreatic neuroendocrine tumour colorectal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-other-topography | NZ cancer gastroenteropancreatic neuroendocrine tumour other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-pancreas-topography | NZ cancer gastroenteropancreatic neuroendocrine tumour pancreas topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-stomach-topography | NZ cancer gastroenteropancreatic neuroendocrine tumour stomach topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-topography | NZ cancer gastroenteropancreatic neuroendocrine tumour topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-german-hodgkin-stage | NZ cancer GHSG Hodgkin treatment stratification stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-colon-topography | NZ cancer gastrointestinal colon topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-colorectal-topography | NZ cancer gastrointestinal colorectal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-duodenum-topography | NZ cancer gastrointestinal duodenum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-exocrine-pancreas-topography | NZ cancer gastrointestinal exocrine pancreas topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-jejunum-ileum-topography | NZ cancer gastrointestinal ileum and jejunum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-liver-topography | NZ cancer gastrointestinal liver topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-oesophagus-topography | NZ cancer gastrointestinal oesophagus topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-pancreas-topography | NZ cancer gastrointestinal pancreas topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-rectum-topography | NZ cancer gastrointestinal rectum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-stomach-topography | NZ cancer gastrointestinal stomach topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-upper-topography | NZ cancer upper gastrointestinal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grade | NZ cancer grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grading-system | NZ cancer grading system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haem-recurrence-type | NZ cancer heamatology recurrence type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-stream | NZ cancer haematology stream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-substream | NZ cancer haematology substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-treatment-intent | NZ cancer haematology treatment intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-cancer-type | NZ cancer head and neck cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-hypopharynx-topography | NZ cancer head and neck hypopharynx topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-larynx-topography | NZ cancer head and neck larynx topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasal-paranasal-topography | NZ cancer head and neck nasal cavity and paranasal sinus topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasal-topography | NZ cancer head and neck nasal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasopharynx-topography | NZ cancer head and neck nasopharynx topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-odontogenic-topography | NZ cancer head and neck odontogenic topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-other-topography | NZ cancer head and neck other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-salivary-gland-topography | NZ cancer head and neck major salivary gland topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-substream | NZ cancer head and neck substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-with-thyroid-topography | NZ cancer head and neck with thyroid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-health-worker-role-path-radio-surg | NZ cancer health worker role pathologist radiologist surgeon |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hep-pan-bil-other-topography | NZ cancer other gastrointestinal hepatopancreaticobiliary topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hep-pan-bil-topography | NZ cancer gastrointestinal hepatopancreaticobiliary topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-high-level-topography | NZ cancer high level topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hl-ips-prognostic-score | NZ cancer Hodgkin lymphoma International Prognostic Score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ipss-r-prognostic-score | NZ cancer IPSS-R for MDS prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-mandatory | NZ cancer laterality mandatory |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-optional | NZ cancer laterality optional |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-or-side | NZ cancer laterality or side |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-side-mandatory | NZ cancer laterality or side mandatory |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-with-unknown | NZ cancer laterality with unknown value |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality | NZ cancer laterality |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lower-gastro-cancer-type | NZ cancer lower gastrointestinal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lugano-lymphoma-stage | NZ cancer Lugano staging classification for lymphoma |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lung-cancer-type | NZ lung cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymph-node-specimen-type | NZ cancer lymph node specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-breast | NZ cancer breast lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-eye-orbit | NZ cancer eye and orbit lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-cervix-uteri | NZ cancer female genital cervix uteri lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-corpus-uteri | NZ cancer female genital corpus uteri lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-vulva | NZ cancer female genital vulva lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-anus | NZ cancer gastrointestinal anus lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-colorectal | NZ cancer gastrointestinal colorectal lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-stomach | NZ cancer gastrointestinal stomach lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal | NZ cancer gastrointestinal lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-head-neck | NZ cancer head and neck lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-male-genital | NZ cancer male genital lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-thorax-lung | NZ cancer thorax lung lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-thorax | NZ cancer thorax lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-kidney | NZ cancer urinary and male genital kidney lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-penis | NZ cancer urinary and male genital penis lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis-ureter | NZ cancer urinary and male genital renal pelvis and ureter lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis | NZ cancer urinary and male genital renal pelvis lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-testis | NZ cancer urinary and male genital testis lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-urinary-bladder | NZ cancer urinary and male genital urinary bladder lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital | NZ cancer urinary and male genital lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary | NZ cancer urinary system lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphoma-substream | NZ cancer lymphoma substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-male-genital-sact-cancer-type | NZ cancer male genital SACT cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-male-genital-topography | NZ cancer male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-malt-ipi-prognostic-score | NZ cancer MALT-IPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mastocytosis-cancer-type | NZ cancer mastocytosis cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-md-anderson-residual-cancer-burden | NZ cancer MD Anderson residual cancer burden |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mds-myeloproliferative-cancer-type | NZ cancer myelodysplastic-myeloproliferative cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-melanoma-cancer-type | NZ cancer melanoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-melanoma-cns-topography | NZ cancer CNS melanoma topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-menopause-status | NZ cancer menopause status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-midline-non-symmetrical-topography | NZ cancer midline non-symmetrical topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-midline-topography | NZ cancer midline topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mipi-prognostic-score | NZ cancer MIPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mipss-70-v2-prognostic-score | NZ cancer MIPSS 70+ v2.0 myelofibrosis prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-cns-cancer-type | NZ cancer medical oncology cns cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-endocrine-cancer-type | NZ cancer medical oncology endocrine cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-endocrine-neuroendocrine-cancer-type | NZ medical oncology cancer endocrine and neuroendocrine cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-genitourinary-cancer-type | NZ cancer medical oncology genitourinary cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-gynaecological-cancer-type | NZ cancer medical oncology gynaecological cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-cancer-type | NZ cancer medical oncology head and neck cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-other-cancer-type | NZ cancer medical oncology other head and neck cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-other-topography | NZ cancer medical oncology head and neck other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-male-genital-topography | NZ cancer medical oncology male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-skin-melanoma-topography | NZ cancer medical oncology skin and/or melanoma topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-skin-topography | NZ cancer medical oncology skin topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-solid-tumour-cancer-type | NZ cancer medical oncology solid tumour cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-solid-tumour-substream | NZ cancer medical oncology solid tumour substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thoracic-cancer-type | NZ cancer medical oncology thoracic cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thoracic-substream | NZ cancer medicial oncology thoracic substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thorax-mesothelioma-topography | NZ cancer thorax medical oncology mesothelioma topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thorax-topography | NZ cancer thorax medical oncology topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-treatment-intent | NZ cancer medical oncology treatment intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-urinary-male-genital-testicular-topography | NZ cancer medical oncology urinary and male genital testicular topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-urinary-male-genital-topography | NZ cancer medical oncology urinary and male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-who-brain-primary-histology | NZ medical oncology WHO brain primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-myeloid-cancer-type | NZ cancer myeloid proliferation and myeloid neoplasm cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nail-topography | NZ cancer nail topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nasal-paranasal-cancer-type | NZ cancer nasal cavity and paranasal sinus cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-benign-reactive-diagnosis | NZ cancer national cervical screening programme benign and reactive diagnosis |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-excision-completeness | NZ cancer national cervical screening programme completeness of excision |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-specimen-type | NZ cancer national cervical screening programme specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-topography | NZ cancer national cervical screening programme topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neoadjuvant-therapy-response-system | NZ cancer neoadjuvant therapy response system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neoadjuvant-therapy-type-non-hormone | NZ cancer neoadjuvant therapy administration type (non-hormone) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-breast-topography | NZ cancer neuroendocrine tumour breast topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-male-genital-topography | NZ cancer neuroendocrine tumour male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-urinary-topography | NZ cancer neuroendocrine tumour urinary topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-gep-cancer-type | NZ cancer neuroendocrine GEP cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-non-gep-cancer-type | NZ cancer neuroendocrine non GEP cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-substream | NZ cancer neuroendocrine substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-ajcc-staging-system | NZ cancer non-AJCC staging system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-hodgkin-lymphoma-cancer-type | NZ cancer non Hodgkin lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-prostate-genitourinary-cancer-type | NZ cancer genitourinary (non prostate) cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-not-performed-reason | NZ cancer not performed reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nottingham-grade | NZ Nottingham Combined grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nuclear-grade | NZ cancer nuclear grade of DCIS grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-observation | NZ cancer observation code |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-parathryoid-topography | NZ cancer parathryoid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-percist-1-cancer-burden | NZ cancer PERCIST 1.0 cancer burden |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-performance-status | NZ cancer performance status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pharynx-larynx-cancer-type | NZ cancer pharynx and larynx and trachea cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pit-prognostic-score | NZ cancer PIT prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pituitary-net-topography | NZ cancer pituitary neuroendocrine tumour topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-polyp-morphology-specimen-type | NZ cancer polyp morphology specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pos-neg-result | NZ cancer positive negative result |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-presence-tumour-finding | NZ cancer presence of tumour finding |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-procedure-status | NZ cancer procedure status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-prognostic-scoring-system | NZ cancer prognostic scoring system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-radiology-type | NZ cancer radiology type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-rai-cll-stage | NZ cancer Rai staging for CLL stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-recist-1-1-cancer-burden | NZ cancer RECIST 1.1 cancer burden |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-recurrence-type | NZ cancer recurrence type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-referral-criteria-procedure-assessment | NZ cancer procedure referral criteria assessment |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-revised-mayo-amyloidosis-stage | NZ cancer revised Mayo staging 2012 for AL (amyloidosis) stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-revised-multiple-myeloma-stage | NZ cancer R-ISS for multiple myeloma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ro-beam-energy-type | NZ cancer radiation oncology beam energy type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ro-planning-technique | NZ cancer radiation oncology planning technique |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-aml-disease-response | NZ SACT acute myeloid leukemia disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-amyloidosis-disease-response | NZ SACT amyloidosis disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-substream | NZ systemtic anti-cancer therapy substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-type | NZ SACT cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cll-sll-disease-response | NZ SACT chronic lymphocytic leukemia and small lymphocytic lymphoma disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cml-disease-response | NZ SACT chronic myeloid leukemia disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-dose-form | NZ SACT dose form |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-dose-unit | NZ SACT dose unit |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-ecog-status | NZ SACT ECOG status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-haem-disease-response | NZ SACT haematology disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-heam-disease-response | NZ SACT heamatology disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-mds-disease-response | NZ SACT myelodysplastic syndrome disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-mo-disease-response | NZ SACT medical oncology disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-non-small-lymphocytic-disease-response | NZ SACT lymphoma (non small lymphocytic) disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-overall-discontinue-reason | NZ SACT overall discontinue reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-patient-factor-discontinue-reason | NZ SACT patient factor discontinue |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-pr-expression | NZ SACT PR expression |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-toxicity-discontinue-reason | NZ systemic anti-cancer therapy toxicity discontinue reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-side-mandatory | NZ cancer side mandatory |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-side | NZ cancer side |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-simple-performance-status | NZ cancer simple performance status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-cancer-type | NZ cancer skin cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-extremity-topography | NZ cancer skin of extremity topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-head-neck-topography | NZ cancer skin of head and neck topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-melanoma-substream | NZ cancer skin and melanoma substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-topography | NZ cancer skin topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-trunk-topography | NZ cancer skin of trunk topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-abdomen-pelvis-topography | NZ cancer soft tissue abdomen and pelvis topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-bone-cancer-type | NZ cancer soft tissue and bone cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-bone-substream | NZ cancer soft tissue and bone substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-extremity-topography | NZ cancer soft tissue extremity topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-head-neck-topography | NZ cancer soft tissue head and neck topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-skin-topography | NZ cancer soft tissue skin topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-thoracic-topography | NZ cancer soft tissue thoracic topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-non-ajcc-staging-system | NZ cancer solid tumour non-AJCC staging system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-sact-cancer-type | NZ cancer solid tumour SACT cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-staging-system | NZ cancer solid tumour staging system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-substream | NZ cancer solid tumour substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-category-excision-biopsy | NZ cancer specimen category biopsy or excision |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-category | NZ cancer specimen category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-colorectal-screening-colonoscopy-type | NZ cancer colorectal screening colonoscopy specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-dimension-type | NZ cancer specimen dimension type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-polyp-profile | NZ cancer polyp profile type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-stage-classification | NZ cancer stage classification |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-intent | NZ surgical intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-margin-proximal-distal | NZ cancer surgical margin qualifier proximal or distal |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-margin-type | NZ cancer surgical margin type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-t-nk-cell-lymphoma-cancer-type | NZ cancer T/NK cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-test-failure-reason | NZ cancer test failure reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-test-inconclusive-reason | NZ cancer test inconclusive reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thoracic-cancer-type | NZ cancer thoracic cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-lung-lobe-topography | NZ cancer thorax lung lobe topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-soft-tissue-topography | NZ cancer thorax soft tissue topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-thymus-topography | NZ cancer thorax thymus topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-topography | NZ cancer thorax topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thryoid-topography | NZ cancer thryoid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thyroid-topography | NZ cancer thyroid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-b-lymphoma-stage | NZ cancer revised TNM-B staging for cutaneous T cell lymphoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-clinical-stage-group | NZ AJCC breast clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-cm | NZ AJCC breast clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-ct | NZ AJCC breast clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pathological-stage-group | NZ AJCC breast pathological stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pn | NZ AJCC breast pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pt | NZ AJCC breast pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-stage-group | NZ AJCC breast stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-clinical-stage-group | NZ AJCC clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-cm | NZ AJCC clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-gen-corpus-uteri-leiomyosarcoma-stage-group | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-cm | NZ AJCC female genital cervix uteri clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-ct | NZ AJCC female genital cervix uteri clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-pm | NZ AJCC female genital cervix uteri pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-pt | NZ AJCC female genital cervix uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-stage-group | NZ AJCC female genital cervix uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-cn | NZ AJCC female genital corpus uteri adenosarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-pt | NZ AJCC female genital corpus uteri adenosarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-cn | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-ct | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-pt | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-stage-group | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-cm | NZ AJCC female genital corpus uteri clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-cn | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-ct | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-pt | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pm | NZ AJCC female genital corpus uteri pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pn | NZ AJCC female genital corpus uteri pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pt | NZ AJCC female genital corpus uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-stage-group | NZ AJCC female genital corpus uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ct | NZ AJCC female genital clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-gestational-pm | NZ AJCC female genital gestational trophoblastic disease pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-gestational-stage-group | NZ AJCC female genital gestational trophoblastic disease stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-cm | NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-pt | NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-pm | NZ AJCC female genital pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-cn | NZ AJCC female genital vagina clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pm | NZ AJCC female genital vagina pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pn | NZ AJCC female genital vagina pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pt | NZ AJCC female genital vagina pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-stage-group | NZ AJCC female genital vagina stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-ct | NZ AJCC female genital vulva clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pm | NZ AJCC female genital vulva pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pn | NZ AJCC female genital vulva pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pt | NZ AJCC female genital vulva pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-clinical-stage-group | NZ AJCC gastrointestinal clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-cn | NZ AJCC gastrointestinal clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-cm | NZ AJCC gastrointestinal colon and rectum clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-cn | NZ AJCC gastrointestinal colon and rectum clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-ct | NZ AJCC gastrointestinal colon and rectum clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-pn | NZ AJCC gastrointestinal colon and rectum pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-stage-group | NZ AJCC gastrointestinal colon and rectum stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-pn | NZ AJCC gastrointestinal pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-yp-stage-group | NZ AJCC gastrointestinal pathological post therapy (neoadjuvant) stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-cm | NZ AJCC gastrointestinal stromal tumour clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-cn | NZ AJCC gastrointestinal stromal tumour clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-ct | NZ AJCC gastrointestinal stromal tumour clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-other-stage-group | NZ AJCC gastrointestinal stromal tumour small intestine and oesophageal and colon and rectum and mesenteric and peritoneal stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-pm | NZ AJCC gastrointestinal stromal tumour pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-pn | NZ AJCC gastrointestinal stromal tumour pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-cll-or-sll-stage-group | NZ AJCC haematology chronic lymphocytic leukemia or small lymphocytic lymphoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-cn | NZ AJCC haematology clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-hl-or-nhl-stage-group | NZ AJCC haematology Hodgkin or non-Hodgkin lymphoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-cm | NZ AJCC haematology mycosis fungoides or sezary syndrome clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-cn | NZ AJCC haematology mycosis fungoides or sezary syndrome clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-ct | NZ AJCC haematology mycosis fungoides or sezary syndrome clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pm | NZ AJCC haematology mycosis fungoides or sezary syndrome pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pn | NZ AJCC haematology mycosis fungoides or sezary syndrome pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pt | NZ AJCC haematology mycosis fungoides or sezary syndrome pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-cm | NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-ct | NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-pm | NZ AJCC haematology cutaneous B cell or T cell non Mycosis fungoides and non-sezary syndrome lymphoma pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-paed-hl-stage-group | NZ AJCC haematology pediatric Hodgkin lymphoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-pn | NZ AJCC haematology pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-pt | NZ AJCC haematology pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-cm | NZ AJCC neuroendocrine gastrointestinal colon and rectum clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-pt | NZ AJCC neuroendocrine gastrointestinal colon and rectum pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-stage-group | NZ AJCC neuroendocrine gastrointestinal colon and rectum stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-ct | NZ AJCC neuroendocrine gastrointestinal clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-pm | NZ AJCC neuroendocrine gastrointestinal pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-pn | NZ AJCC neuroendocrine gastrointestinal pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-stage-group | NZ AJCC neuroendocrine gastrointestinal stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pathological-stage-group | NZ AJCC pathological stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pm | NZ AJCC pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pt | NZ AJCC pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-rcn | NZ AJCC recurrence or retreatment clinical N category (rcN) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-rpn | NZ AJCC recurrence or retreatment pathological N category (rpN) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-stage-classification | NZ TNM stage classification |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-stage-clinical-classification | NZ clinical TNM stage classification |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-suffix | NZ TNM suffix |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-cn | NZ AJCC thoracic clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-ct | NZ AJCC thoracic clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-cm | NZ AJCC thoracic lung clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-cn | NZ AJCC thoracic lung clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-stage-group | NZ AJCC thoracic lung stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-cn | NZ AJCC thoracic malignant pleural mesothelioma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pm | NZ AJCC thoracic malignant pleural mesothelioma pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pn | NZ AJCC thoracic malignant pleural mesothelioma pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pt | NZ AJCC thoracic malignant pleural mesothelioma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-stage-group | NZ AJCC thoracic malignant pleural mesothelioma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pn | NZ AJCC thoracic pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-stage-group | NZ AJCC thoracic stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-cm | NZ AJCC thoracic thymus clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-cn | NZ AJCC thoracic thymus clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-ct | NZ AJCC thoracic thymus clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-pt | NZ AJCC thoracic thymus pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-stage-group | NZ AJCC thoracic thymus stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-ypn | NZ AJCC post therapy (neoadjuvant) pathological N category (ypN) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-clinical-stage-group | NZ AJCC (8th edition) breast clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-cn | NZ AJCC (8th edition) breast clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-ct | NZ AJCC (8th edition) breast clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-pn | NZ AJCC (8th edition) breast pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-pt | NZ AJCC (8th edition) breast pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-gen-ovary-fallopian-peritoneal-stage-group | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-cm | NZ AJCC (8th edition) female genital cervix uteri clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-pt | NZ AJCC (8th edition) female genital cervix uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-stage-group | NZ AJCC (8th edition) female genital cervix uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cn | NZ AJCC (8th edition) female genital clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-adenosarcoma-ct | NZ AJCC (8th edition) female genital corpus uteri adenosarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-adenosarcoma-pt | NZ AJCC (8th edition) female genital corpus uteri adenosarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-carcinoma-ct | NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-carcinoma-stage-group | NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-cn | NZ AJCC (8th edition) female genital corpus uteri clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-cn | NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-ct | NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-pt | NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-pn | NZ AJCC (8th edition) female genital corpus uteri pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-pt | NZ AJCC (8th edition) female genital corpus uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-stage-group | NZ AJCC (8th edition) female genital corpus uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ct | NZ AJCC (8th edition) female genital clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-gestational-pm | NZ AJCC (8th edition) female genital gestational trophoblastic disease pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-gestational-stage-group | NZ AJCC (8th edition) female genital gestational trophoblastic disease stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-cm | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-ct | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-pm | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-pn | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-pm | NZ AJCC (8th edition) female genital pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-pt | NZ AJCC (8th edition) female genital pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-stage-group | NZ AJCC (8th edition) female genital stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-pm | NZ AJCC (8th edition) female genital vagina pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-pt | NZ AJCC (8th edition) female genital vagina pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-stage-group | NZ AJCC (8th edition) female genital vagina stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-cm | NZ AJCC (8th edition) female genital vulva clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-cn | NZ AJCC (8th edition) female genital vulva clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pm | NZ AJCC (8th edition) female genital vulva pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pn | NZ AJCC (8th edition) female genital vulva pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pt | NZ AJCC (8th edition) female genital vulva pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-stage-group | NZ AJCC (8th edition) female genital vulva stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-clinical-stage-group | NZ AJCC (8th edition) gastrointestinal clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-cn | NZ AJCC (8th edition) gastrointestinal colon and rectum clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-ct | NZ AJCC (8th edition) gastrointestinal colon and rectum clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pm | NZ AJCC (8th edition) gastrointestinal colon and rectum pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pn | NZ AJCC (8th edition) gastrointestinal colon and rectum pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pt | NZ AJCC (8th edition) gastrointestinal colon and rectum pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-stage-group | NZ AJCC (8th edition) gastrointestinal colon and rectum stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pathological-stage-group | NZ AJCC (8th edition) gastrointestinal pathological stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pn | NZ AJCC (8th edition) gastrointestinal pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pt | NZ AJCC (8th edition) gastrointestinal pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-yp-stage-group | NZ AJCC (8th edition) gastrointestinal pathological post therapy (neoadjuvant) stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-cn | NZ AJCC (8th edition) gastrointestinal stromal tumour clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-ct | NZ AJCC (8th edition) gastrointestinal stromal tumour clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pm | NZ AJCC (8th edition) gastrointestinal stromal tumour pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pn | NZ AJCC (8th edition) gastrointestinal stromal tumour pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pt | NZ AJCC (8th edition) gastrointestinal stromal tumour pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-cm | NZ AJCC (8th edition) haematology clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-cn | NZ AJCC (8th edition) haematology clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-ct | NZ AJCC (8th edition) haematology clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-hl-or-nhl-stage-group | NZ AJCC (8th edition) haematology Hodgkin or non Hodgkin lymphoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-cm | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-cn | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-ct | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pm | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pn | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pt | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-cm | NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-ct | NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pm | NZ AJCC (8th edition) haematology cutaneous B cell or T cell non mycosis fungoides and non sezary syndrome lymphoma pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pt | NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-paed-hl-stage-group | NZ AJCC (8th edition) haematology pediatric Hodgkin lymphoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-pcm-stage-group | NZ AJCC (8th edition) haematology plasma cell myeloma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-pn | NZ AJCC (8th edition) haematology pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-stage-group | NZ AJCC (8th edition) haematology stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-cn | NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cm | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cn | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pm | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pt | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pm | NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pn | NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pt | NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-stage-group | NZ AJCC (8th edition) neuroendocrine gastrointestinal stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-cm | NZ AJCC (8th edition) thoracic clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-ct | NZ AJCC (8th edition) thoracic lung clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-pn | NZ AJCC (8th edition) thoracic lung pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-pt | NZ AJCC (8th edition) thoracic lung pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-stage-group | NZ AJCC (8th edition) thoracic lung stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-cn | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-ct | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-pm | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-stage-group | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pn | NZ AJCC (8th edition) thoracic pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pt | NZ AJCC (8th edition) thoracic pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-cm | NZ AJCC (8th edition) thoracic thymus clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-cn | NZ AJCC (8th edition) thoracic thymus clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-pm | NZ AJCC (8th edition) thoracic thymus pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-stage-group | NZ AJCC (8th edition) thoracic thymus stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-cm | NZ AJCC (9th edition) female genital cervix uteri clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-cn | NZ AJCC (9th edition) female genital cervix uteri clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-ct | NZ AJCC (9th edition) female genital cervix uteri clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-pt | NZ AJCC (9th edition) female genital cervix uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-stage-group | NZ AJCC (9th edition) female genital cervix uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cm | NZ AJCC (9th edition) female genital clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cn | NZ AJCC (9th edition) female genital clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-ct | NZ AJCC (9th edition) female genital clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-pm | NZ AJCC (9th edition) female genital pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-pn | NZ AJCC (9th edition) female genital pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-vulva-cn | NZ AJCC (9th edition) female genital vulva clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-vulva-pm | NZ AJCC (9th edition) female genital vulva pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-vulva-pn | NZ AJCC (9th edition) female genital vulva pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-treatment-intent | NZ cancer treatment intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tumour-focality | NZ cancer tumour focality |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tumour-origin | NZ cancer tumour origin |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-unknown-site-topography | NZ cancer unknown site topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-upper-gastro-cancer-type | NZ cancer upper gastrointestinal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-kidney-topography | NZ cancer urinary and male genital kidney topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-prostate-topography | NZ cancer urinary and male genital prostate topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-renal-pelvis-ureter-topography | NZ cancer urinary and male genital renal pelvis and ureter topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-testicular-adnexa-topography | NZ cancer urinary and male genital testicular adnexa topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-testicular-topography | NZ cancer urinary and male genital testicular topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-testis-topography | NZ cancer urinary and male genital testis topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-urinary-bladder-topography | NZ cancer urinary and male genital urinary bladder topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-system-cancer-type | NZ cancer urinary system cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-topography | NZ cancer urinary system topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-aggressive-nh-bcell-lymphoma-histology | NZ WHO haematolymphoid aggressive non-hodgkin B cell lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-anus-primary-histology | NZ WHO anus primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-appendix-site-histology | NZ WHO appendix site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-bladder-primary-histology | NZ WHO urinary bladder primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-bone-haematolymphoid-histology | NZ WHO bone haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-bone-histology | NZ WHO bone histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-brain-primary-histology | NZ WHO brain primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-brain-site-histology | NZ WHO brain site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-haematolymphoid-histology | NZ WHO breast haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-in-situ-carcinoma-histology | NZ WHO breast ductal carcinoma in situ histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-invasive-carcinoma-histology | NZ WHO breast invasive carcinoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-invasive-histology | NZ WHO breast invasive histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-nipple-histology | NZ WHO breast tumour of nipple histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-primary-histology | NZ WHO breast primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-uncertain-borderline-histology | NZ WHO breast uncertain and borderline histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-cranial-paraspinal-nerve-histology | NZ WHO central nervous system cranial and paraspinal nerve histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-grade | NZ WHO central nervous system tumour grade reference set |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-haematolymphoid-histology | NZ WHO central nervous system haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-melanocytic-histology | NZ WHO central nervous system melanocytic histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-meningioma-histology | NZ WHO central nervous system meningioma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-pineal-histology | NZ WHO central nervous system pineal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-sellar-region-histology | NZ WHO central nervous system sellar region histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-colorectal-primary-histology | NZ WHO colorectal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-colorectal-site-histology | NZ WHO colorectal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-conjunctiva-primary-histology | NZ WHO conjunctiva primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-differentiation-excl-undifferentiated-grade | NZ WHO malignant differentiation excluding undifferentiated grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-differentiation-grade | NZ WHO malignant differentiation grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-appendix-histology | NZ WHO digestive system appendix histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-colon-rectum-histology | NZ WHO digestive system colon and rectum histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-malignant-histology | NZ WHO digestive system malignant tumour histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-mesenchymal-histology | NZ WHO digestive system mesenchymal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-oesophagus-histology | NZ WHO digestive system oesophagus histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-uncertain-histology | NZ WHO digestive system uncertain behaviour tumour histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-histology | NZ WHO endocrine and neuroendocrine adrenal gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-primary-histology | NZ WHO endocrine and neuroendocrine adrenal cortex primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-site-histology | NZ WHO endocrine and neuroendocrine adrenal cortex site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-medulla-primary-histology | NZ WHO endocrine and neuroendocrine adrenal medulla primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-primary-histology | NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-site-histology | NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-germ-cell-histology | NZ WHO endocrine and neuroendocrine germ cell histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-malignant-histology | NZ WHO endocrine and neuroendocrine malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-paraganglioma-primary-histology | NZ WHO endocrine and neuroendocrine paraganglioma primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-parathyroid-primary-histology | NZ WHO endocrine and neuroendocrine parathyroid gland primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-parathyroid-site-histology | NZ WHO endocrine and neuroendocrine parathyroid gland site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-pituitary-histology | NZ WHO endocrine and neuroendocrine pituitary gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-primary-pituitary-histology | NZ WHO endocrine and neuroendocrine pituitary gland primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-primary-pituitary-net-histology | NZ WHO pituitary neuroendocrine tumour primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-thyroid-histology | NZ WHO endocrine and neuroendocrine thyroid gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-thyroid-primary-histology | NZ WHO endocrine and neuroendocrine thyroid gland primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-uncertain-histology | NZ WHO endocrine and neuroendocrine uncertain behaviour histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-primary-histology | NZ WHO endocrine primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-behaviour-free-histology | NZ WHO eye and orbit behaviour free histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-eyelid-histology | NZ WHO eye and orbit eyelid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-haematolymphoid-histology | NZ WHO eye and orbit haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-in-situ-histology | NZ WHO eye and orbit in situ histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-lacrimal-gland-histology | NZ WHO eye and orbit lacrimal gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-optic-disc-nerve-histology | NZ WHO eye and orbit optic disc and optic nerve histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-uveal-tract-histology | NZ WHO eye and orbit uveal tract histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eyelid-site-histology | NZ WHO eyelid site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-fallopian-tube-primary-histology | NZ WHO fallopian tube primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-breast-primary-minus-nipple-histology | NZ WHO female breast primary (no nipple) histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-gestational-trophoblastic-histology | NZ WHO female genital gestational trophoblastic disease histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-haematolymphoid-histology | NZ WHO female genital haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-histology | NZ WHO female genital histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-melanocytic-histology | NZ WHO female genital melanocytic lesion histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-mesenchymal-histology | NZ WHO female genital mesenchymal tumour of lower genital tract histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-neuroendocrine-histology | NZ WHO female genital neuroendocrine histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-ovary-histology | NZ WHO female genital ovary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-peritoneum-histology | NZ WHO female genital peritoneum histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-uterine-ligament-histology | NZ WHO female genital uterine ligament histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-vagina-histology | NZ WHO female genital vagina histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-vulva-histology | NZ WHO female genital vulva histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-gep-net-primary-histology | NZ WHO neuroendocrine tumour gastroenteropancreatic (GEP-NET) primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-gestational-trophoblastic-site-histology | NZ WHO gestational trophoblastic site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-all-bcell-histology | NZ WHO haematolymphoid B lymphoblastic leukaemia lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-all-histology | NZ WHO haematolymphoid acute lymphoblastic leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-all-tcell-histology | NZ WHO haematolymphoid T lymphoblastic leukemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-b-cell-histology | NZ WHO hematolymphoid B cell lymphoid proliferation or lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-b-cell-lymphoid-histology | NZ WHO haematolymphoid B cell lymphoid neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-b-cell-lymphoma-histology | NZ WHO haematolymphoid B cell lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-bl-histology | NZ WHO haematolymphoid Burkitt lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-castleman-disorder-histology | NZ WHO haematolymphoid Castleman disease histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-chronic-leukaemia-histology | NZ WHO haematolymphoid chronic leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-cmml-histology | NZ WHO haematolymphoid chronic myelomonocytic leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-cnl-histology | NZ WHO haematolymphoid chronic neutrophilic leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-cutaneous-t-cell-lymphoma-histology | NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-et-histology | NZ WHO haematolymphoid essential thrombocythaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-extranod-nk-t-cell-lymphoid-histology | NZ WHO haematolymphoid extranodal NK/T cell lymphoid proliferation histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-extranod-nk-t-cell-lymphoma-histology | NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-hcl-histology | NZ WHO haematolymphoid hairy cell leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-histiocytic-histology | NZ WHO hematolymphoid histiocytic dendritic cell neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-histiocytic-other-histology | NZ WHO haematolymphoid histiocytic dendritic cell neoplasm other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-intestinal-nk-t-cell-lymphoid-histology | NZ WHO classification of tumours haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-leukaemia-histology | NZ WHO haematolymphoid leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-lymphoma-not-sll-histology | NZ WHO haematolymphoid lymphoma excluding small lymphocytic disease histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-lymphoplasmacytic-lymphoma-histology | NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mast-cell-sarcoma-histology | NZ WHO haematolymphoid mast cell sarcoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mastocytosis-other-histology | NZ WHO haematolymphoid mastocytosis other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mc-lymphoma-histology | NZ WHO haematolymphoid mantle cell lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mds-histology | NZ WHO haematolymphoid myelodysplastic syndrome histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mds-myeloproliferative-histology | NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mds-myeloproliferative-other-histology | NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mpn-other-histology | NZ WHO haematolymphoid myeloproliferative neoplasm other leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloid-histology | NZ WHO hematolymphoid myeloid proliferation or neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloid-other-histology | NZ WHO haematolymphoid myeloid proliferation or neoplasm other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloid-secondary-histology | NZ WHO classification of tumours haematolymphoid secondary myeloid neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloma-histology | NZ WHO haematolymphoid myeloma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloproliferative-neoplasm-histology | NZ WHO haematology chronic myeloproliferative neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mzl-histology | NZ WHO haematolymphoid marginal zone lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-plasma-cell-other-histology | NZ WHO haematolymphoid plasma cell neoplasm and other diseases with paraproteins other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-primary-cns-lymphoma-histology | NZ WHO haematolymphoid primary CNS lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-sll-histology | NZ WHO haematolymphoid small lymphocytic lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-stroma-histology | NZ WHO hematolymphoid stroma derived neoplasm of lymphoid tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-sys-mastocytosis-histology | NZ WHO haematolymphoid systemic mastocytosis histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-t-nk-cell-histology | NZ WHO hematolymphoid T cell and NK cell lymphoid proliferation or lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-t-nk-cell-other-histology | NZ WHO haematolymphoid T-cell and natural killer cell neoplasm other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-benign-histology | NZ WHO classification of tumours head and neck benign histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-ear-histology | NZ WHO classification of tumours head and neck ear histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-germ-cell-histology | NZ WHO classification of tumours head and neck germ cell tumour histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-haematolymphoid-histology | NZ WHO classification of tumours head and neck haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-histology | NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-primary-histology | NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-site-histology | NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-malignant-histology | NZ WHO classification of tumours head and neck malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-melanocytic-histology | NZ WHO classification of tumours head and neck melanocytic histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-primary-histology | NZ WHO classification of tumours head and neck nasal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-site-histology | NZ WHO classification of tumours head and neck nasal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-skull-histology | NZ WHO classification of tumours head and neck nasal and paranasal and skull base histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-skull-primary-histology | NZ WHO classification of tumours head and neck nasal and paranasal and skull base primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-skull-site-histology | NZ WHO classification of tumours head and neck nasal and paranasal and skull base site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasopharynx-histology | NZ WHO classification of tumours head and neck nasopharynx histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasopharynx-site-histology | NZ WHO classification of tumours head and neck nasopharynx site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-neuro-paragang-histology | NZ WHO classification of tumours head and neck neuroendocrine neoplasm and paraganglioma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-odontogenic-maxfac-histology | NZ WHO classification of tumours head and neck odontogenic and maxillofacial bone histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-odontogenic-maxfac-primary-histology | NZ WHO classification of tumours head and neck odontogenic and maxillofacial bone primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oral-cavity-histology | NZ WHO classification of tumours head and neck oral cavity and mobile tongue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oral-cavity-primary-histology | NZ WHO classification of tumours head and neck oral cavity and mobile tongue primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oropharynx-histology | NZ WHO classification of tumours head and neck oropharynx histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oropharynx-primary-histology | NZ WHO classification of tumours head and neck oropharynx primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-pharynx-larynx-trachea-primary-histology | NZ WHO classification of tumours head and neck pharynx and larynx and trachea primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-pharynx-larynx-trachea-site-histology | NZ WHO classification of tumours head and neck pharynx and larynx and trachea site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-salivary-histology | NZ WHO classification of tumours head and neck salivary gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-salivary-primary-histology | NZ WHO classification of tumours head and neck salivary gland primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-salivary-site-histology | NZ WHO classification of tumours head and neck salivary gland site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-soft-tissue-histology | NZ WHO classification of tumours head and neck soft tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-uncertain-histology | NZ WHO classification of tumours head and neck uncertain behaviour histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-heart-primary-histology | NZ WHO heart primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-histology-cll-histology | NZ WHO haematolymphoid chronic lymphocytic leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-histology-plasmacytoid-dendritic-histology | NZ WHO haematolymphoid plasmacytoid dendritic cell neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-histology | NZ WHO histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-indolent-b-cell-lymphoma-other-histology | NZ WHO haematolymphoid indolent B cell lymphoma other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-indolent-bcell-lymphoma-histology | NZ WHO haematolymphoid indolent B cell lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-indolent-nh-b-cell-lymphoma-other-histology | NZ WHO haematolymphoid indolent non-hodgkin B cell lymphoma other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-kidney-primary-histology | NZ WHO kidney primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lacrimal-drainage-system-primary-histology | NZ WHO lacrimal drainage system primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lacrimal-gland-primary-histology | NZ WHO lacrimal gland primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lacrimal-gland-site-histology | NZ WHO lacrimal gland site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-liver-site-histology | NZ WHO liver site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-low-high-diff-grade | NZ WHO malignant low high (differentiation) grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lower-gastro-primary-histology | NZ WHO lower gastrointestinal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lower-gastro-site-histology | NZ WHO lower gastrointestinal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-male-breast-primary-histology | NZ WHO male breast primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-mature-tnk-cell-other-histology | NZ WHO haematolymphoid mature T-cell and natural killer cell neoplasm other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-mature-tnk-leukaemia-histology | NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-melanoma-cns-primary-histology | NZ WHO classification of CNS melanoma primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-melanoma-primary-histology | NZ WHO classification of melanoma primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-meninges-primary-histology | NZ WHO meninges primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-mo-histology | NZ WHO medical oncology histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-net-non-endo-organ-primary-histology | NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendo-non-endo-organ-histology | NZ WHO neuroendocrine neoplasm non neuroendocrine organ histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendo-pancreas-histology | NZ WHO neuroendocrine pancreas histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendo-pancreas-primary-histology | NZ WHO neuroendocrine pancreas primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendocrine-grade | NZ WHO neuroendocrine tumour grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-oesophagus-primary-histology | NZ WHO oesophagus primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-orbit-histology | NZ WHO orbit histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-orbit-primary-histology | NZ WHO orbit primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-ovary-primary-histology | NZ WHO ovary primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-ovary-site-histology | NZ WHO ovary site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pancreas-primary-histology | NZ WHO pancreas primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pancreas-site-histology | NZ WHO pancreas site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-penis-primary-histology | NZ WHO penis primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-penis-site-histology | NZ WHO penis site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pericardium-primary-histology | NZ WHO pericardium primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pericardium-site-histology | NZ WHO pericardium site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-peritoneum-site-histology | NZ WHO peritoneum site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pleura-site-histology | NZ WHO pleural site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-prostate-primary-histology | NZ WHO prostate primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-prostate-site-histology | NZ WHO prostate site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-sclera-primary-histology | NZ WHO sclera primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-heamatolymphoid-histology | NZ WHO classification of tumours skin haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-keratinocytic-epidermal-histology | NZ WHO classification of tumours skin keratinocytic and epidermal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-malignant-histology | NZ WHO classification of tumours skin malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-melanocytic-histology | NZ WHO classification of tumours skin melanocytic neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-merkel-primary-histology | NZ WHO classification of Merkel cell carcinoma primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-precursor-histology | NZ WHO classification of tumours skin precursor histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-squamous-primary-histology | NZ WHO classification of squamous cell carcinoma primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-small-intestine-primary-histology | NZ WHO small intestine primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-small-intestine-site-histology | NZ WHO small intestine site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-bone-undiff-sarcoma-histology | NZ WHO soft tissue and bone undifferentiated small round cell sarcoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-histology | NZ WHO soft tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-primary-histology | NZ WHO soft tissue primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-site-histology | NZ WHO soft tissue site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-spinal-cord-site-histology | NZ WHO spinal cord site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-stomach-primary-histology | NZ WHO stomach primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testicular-adnexa-primary-histology | NZ WHO testicular adnexa primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testicular-adnexa-site-histology | NZ WHO testicular adnexa site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testis-primary-histology | NZ WHO testis primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testis-site-histology | NZ WHO testis site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-benign-histology | NZ WHO thoracic benign histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-ectopic-thyroid-parathyroid-histology | NZ WHO thoracic ectopic tumour of thyroid and parathyroid origin histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-haematolymphoid-histology | NZ WHO thoracic haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-malignant-histology | NZ WHO thoracic malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-mesenchymal-histology | NZ WHO thoracic mesenchymal thorax histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-neuroendocrine-grade | NZ WHO thoracic neuroendocrine tumour grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-non-small-cell-lung-histology | NZ WHO thoracic non small cell lung histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-pleura-pericardium-histology | NZ WHO thoracic pleura and pericardium histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-precursor-histology | NZ WHO thoracic precursor histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-primary-histology | NZ WHO thoracic primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-small-cell-lung-histology | NZ WHO thoracic small cell lung histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-upper-gastro-primary-histology | NZ WHO upper gastrointestinal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-upper-gastro-site-histology | NZ WHO upper gastrointestinal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urethra-primary-histology | NZ WHO urethra primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urethra-site-histology | NZ WHO urethra site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-histology | NZ WHO urinary and male genital histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-kidney-germ-cell-histology | NZ WHO urinary and male genital kidney germ cell histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-kidney-histology | NZ WHO urinary and male genital kidney histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-neuroendocrine-histology | NZ WHO urinary and male genital neuroendocrine histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-primary-histology | NZ WHO urinary and male genital primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-prostate-histology | NZ WHO urinary and male genital prostate histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testicular-adnexa-histology | NZ WHO urinary and male genital testicular adnexa histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testis-germ-cell-histology | NZ WHO urinary and male genital testis germ cell histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testis-histology | NZ WHO urinary and male genital testis histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-system-site-histology | NZ WHO urinary system site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-corpus-primary-histology | NZ WHO uterine corpus primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-corpus-site-histology | NZ WHO uterine corpus site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-ligament-site-histology | NZ WHO uterine ligament site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-primary-histology | NZ WHO uterine primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uveal-tract-site-histology | NZ WHO uveal tract site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vagina-site-histology | NZ WHO vagina site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vulva-primary-histology | NZ WHO vulva primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vulva-site-histology | NZ WHO vulva site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-aggressive-bcell-lymphoma-histology | NZ WHO haematolymphoid aggressive cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-aggressive-nh-bcell-lymphoma-histology | NZ WHO haematolymphoid aggressive non-Hodgkin B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-bone-histology | NZ WHO bone histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-behaviour-free-histology | NZ WHO breast behaviour free histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-benign-histology | NZ WHO breast benign histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-haematolymphoid-histology | NZ WHO breast haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-histology | NZ WHO breast histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-nipple-histology | NZ WHO breast tumour of nipple histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-choroid-plexus-histology | NZ WHO central nervous system choroid plexus histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-cranial-paraspinal-nerve-histology | NZ WHO central nervous system cranial and paraspinal nerve histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-embryonal-histology | NZ WHO central nervous system embryonal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-germ-cell-histology | NZ WHO central nervous system germ cell histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-glioma-glioneuronal-neuronal-histology | NZ WHO central nervous system glioma and glioneuronal and neuronal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-haematolymphoid-histology | NZ WHO central nervous system haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-pineal-histology | NZ WHO central nervous system pineal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-sellar-region-histology | NZ WHO central nervous system sellar region histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-differentiation-grade | NZ WHO (5th edition) malignant differentiation grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-anal-canal-histology | NZ WHO digestive system anal canal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-appendix-histology | NZ WHO digestive system appendix histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-benign-histology | NZ WHO digestive system benign tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-colon-rectum-hormone-histology | NZ WHO digestive system colon and rectum hormone producing tumor histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-germ-tumour-histology | NZ WHO digestive system germ cell tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-haematolymphoid-histology | NZ WHO digestive system haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-liver-intrahepatic-bile-duct-histology | NZ WHO digestive system liver and intrahepatic bile duct histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-mesenchymal-histology | NZ WHO digestive system mesenchymal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-precursor-histology | NZ WHO digestive system precursor tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-uncertain-histology | NZ WHO digestive system uncertain behaviour tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-adrenal-histology | NZ WHO endocrine and neuroendocrine adrenal gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-benign-histology | NZ WHO endocrine and neuroendocrine benign histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-malignant-histology | NZ WHO endocrine and neuroendocrine malignant histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-pituitary-histology | NZ WHO endocrine and neuroendocrine pituitary gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-pituitary-net-histology | NZ WHO pituitary neuroendocrine tumour primary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-thyroid-histology | NZ WHO endocrine and neuroendocrine thyroid gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-uncertain-histology | NZ WHO endocrine and neuroendocrine uncertain behaviour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-haematolymphoid-histology | NZ WHO eye and orbit haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-histology | NZ WHO eye and orbit histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-lacrimal-gland-histology | NZ WHO eye and orbit lacrimal gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-optic-disc-nerve-histology | NZ WHO eye and orbit optic disc and optic nerve histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-retina-neuroepithelium-histology | NZ WHO eye and orbit retina and neuroepithelium histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-soft-tissue-bone-histology | NZ WHO eye and orbit soft tissue and bone histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-uncertain-borderline-histology | NZ WHO eye and orbit uncertain and borderline histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-germ-cell-histology | NZ WHO female genital germ cell histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-haematolymphoid-histology | NZ WHO female genital haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-neuroendocrine-histology | NZ WHO female genital neuroendocrine histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-ovary-histology | NZ WHO female genital ovary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-peritoneum-histology | NZ WHO female genital peritoneum histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-vagina-histology | NZ WHO female genital vagina histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-acute-leukaemia-amb-lineage-histology | NZ WHO haematolymphoid acute leukaemia of mixed or ambiguous lineage histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-amyloidosis-histology | NZ WHO haematolymphoid amyloidosis histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-b-cell-lymphoma-histology | NZ WHO haematolymphoid B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-b-cell-reactive-lymphoma-histology | NZ WHO haematolymphoid reactive B-cell rich lymphoid proliferations which mimic lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-bl-histology | NZ WHO haematolymphoid Burkitt lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-castleman-disorder-histology | NZ WHO haematolymphoid Castleman disease histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-cml-histology | NZ WHO haematolymphoid chronic myeloid leukaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-cutaneous-t-cell-lymphoma-histology | NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-et-histology | NZ WHO haematolymphoid essential thrombocythaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-extranod-nk-t-cell-lymphoma-histology | NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-histiocytic-histology | NZ WHO haematolymphoid histiocytic dendritic cell neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-histology | NZ WHO haematolymphoid tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-intest-nk-t-cell-lymphoid-histology | NZ WHO classification of tumours (5th edition) haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-leukaemia-histology | NZ WHO haematolymphoid leukaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-lymphoplasmacytic-lymphoma-histology | NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mc-lymphoma-histology | NZ WHO haematolymphoid mantle cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mds-histology | NZ WHO haematolymphoid myelodysplastic syndrome histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mds-myeloproliferative-histology | NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloid-lymphoid-gene-histology | NZ WHO haematolymphoid myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloid-secondary-histology | NZ WHO classification of tumours (5th edition) haematolymphoid secondary myeloid neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloproliferative-neoplasm-histology | NZ WHO haematology chronic myeloproliferative neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-nhl-histology | NZ WHO haematolymphoid non Hodgkin lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-peripheral-t-cell-lymphoma-histology | NZ WHO haematolymphoid peripheral T cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-plasma-cell-histology | NZ WHO haematolymphoid plasma cell neoplasms and other diseases with paraproteins histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-pv-histology | NZ WHO haematolymphoid polycythaemia vera histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-benign-histology | NZ WHO classification of tumours (5th edition) head and neck benign histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-ear-histology | NZ WHO classification of tumours (5th edition) head and neck ear histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-haematolymphoid-histology | NZ WHO classification of tumours (5th edition) head and neck haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-histology | NZ WHO classification of tumours (5th edition) head and neck histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-malignant-histology | NZ WHO classification of tumours (5th edition) head and neck malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-melanocytic-histology | NZ WHO classification of tumours (5th edition) head and neck melanocytic histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-nasal-skull-histology | NZ WHO classification of tumours (5th edition) head and neck nasal and paranasal and skull base histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-nasopharynx-histology | NZ WHO classification of tumours (5th edition) head and neck nasopharynx histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-neck-lymph-histology | NZ WHO classification of tumours (5th edition) head and neck tumour and tumour-like lesion of the neck and lymph node histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-odontogenic-maxfac-histology | NZ WHO classification of tumours (5th edition) head and neck odontogenic and maxillofacial bone histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-oral-cavity-histology | NZ WHO classification of tumours (5th edition) head and neck oral cavity and mobile tongue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-pharynx-larynx-histology | NZ WHO classification of tumours (5th edition) head and neck hypopharynx and larynx and trachea and parapharyngeal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-precursor-histology | NZ WHO classification of tumours (5th edition) head and neck precursor histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-salivary-histology | NZ WHO classification of tumours (5th edition) head and neck salivary gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-soft-tissue-histology | NZ WHO classification of tumours (5th edition) head and neck soft tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-histology-cll-histology | NZ WHO haematolymphoid chronic lymphocytic leukaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-indolent-bcell-lymphoma-histology | NZ WHO haematolymphoid indolent B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-indolent-nh-bcell-lymphoma-histology | NZ WHO haematolymphoid indolent non-Hodgkin B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-low-high-diff-grade | NZ WHO (5th edition) malignant low high (differentiation) grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-mature-tnk-cell-histology | NZ WHO haematolymphoid mature T cell and natural killer cell neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-mature-tnk-leukaemia-histology | NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-cns-histology | NZ WHO classification of tumours (5th edition) CNS melanoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-histology | NZ WHO classification of tumours (5th edition) melanoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-mucosal-histology | NZ WHO classification of tumours (5th edition) mucosal melanoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-monoclonal-b-cell-lymphocytosis-histology | NZ WHO haematolymphoid monoclonal B cell lymphocytosis histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-net-non-endo-organ-histology | NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-neuroendo-pancreas-histology | NZ WHO neuroendocrine pancreas histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-neuroendo-pancreas-net-histology | NZ WHO neuroendocrine tumour pancreas primary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-orbit-histology | NZ WHO orbit histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-heamatolymphoid-histology | NZ WHO classification of tumours (5th edition) skin haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-histology | NZ WHO classification of tumours (5th edition) skin histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-keratinocytic-epidermal-histology | NZ WHO classification of tumours (5th edition) skin keratinocytic and epidermal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-merkel-histology | NZ WHO classification of tumours (5th edition) Merkel cell carcinoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-precursor-histology | NZ WHO classification of tumours (5th edition) skin precursor histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-soft-tissue-histology | NZ WHO classification of tumours (5th edition) skin soft tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-soft-tissue-bone-undiff-sarcoma-histology | NZ WHO soft tissue and bone undifferentiated small round cell sarcoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-benign-histology | NZ WHO thoracic benign histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-ectopic-thyroid-parathyroid-histology | NZ WHO thoracic ectopic tumour of thyroid and parathyroid origin histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-germ-cell-mediastinum-histology | NZ WHO thoracic mediastinum germ cell histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-haematolymphoid-mediastinum-histology | NZ WHO thoracic mediastinum haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-heart-histology | NZ WHO thoracic heart histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-neuroendocrine-grade | NZ WHO (5th edition) thoracic neuroendocrine tumour grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-non-small-cell-lung-histology | NZ WHO thoracic non small cell lung histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-pleura-pericardium-histology | NZ WHO thoracic pleura and pericardium histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-precursor-histology | NZ WHO thoracic precursor histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-small-cell-lung-histology | NZ WHO thoracic small cell lung histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-haematolymphoid-histology | NZ WHO urinary and male genital haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-histology | NZ WHO urinary and male genital histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-kidney-histology | NZ WHO urinary and male genital kidney histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-prostate-histology | NZ WHO urinary and male genital prostate histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-testis-germ-cell-histology | NZ WHO urinary and male genital testis germ cell histology (5th edition) |
http://hl7.org/fhir/ValueSet/condition-severity | Condition/Diagnosis Severity |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-hypercholesterolaemia | CVDRA Hypercholesterolaemia |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-angina | CVDRA Angina |
http://hl7.org/fhir/uv/ips/ValueSet/medication-snomed-uv-ips | Medications - SNOMED CT (IPS) |
https://nzhts.digital.health.nz/fhir/ValueSet/practitioner-role-code | PractitionerRoleCode |
http://hl7.org/fhir/uv/ips/ValueSet/problems-snomed-uv-ips | Problems (SNOMED CT) - IPS |
http://hl7.org/fhir/ValueSet/reason-medication-status-codes | SNOMED CT Drug Therapy Status codes |
http://hl7.org/fhir/uv/ips/ValueSet/result-coded-value-pathology-uv-ips | Results Coded Values Pathology - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-coded-values-laboratory-uv-ips | Results Coded Values Laboratory - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-presence-absence-uv-ips | Results Presence/Absence - IPS |
http://hl7.org/fhir/us/davinci-crd/ValueSet/serviceRequestCodes | CRD Service Request Codes Value Set |
http://who-umc.org/idmp/ValueSet/routeOfAdministration | Route Of Administration |
http://hl7.dk/fhir/Hackathon-Sep-2022/ValueSet/ActivityCodes | ObservationCodes |
http://hl7.dk/fhir/Hackathon-Sep-2022/ValueSet/ObservationCodesSCT | ObservationCodesSCT |
http://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType | Adverse Event Type |
http://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug | Allergen No Drug |
http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup | Blood Group |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite | Body Site |
http://terminology.ehdsi.eu/ValueSet/eHDSICodeProb | Problems |
http://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus | Current Pregnancy Status |
http://terminology.ehdsi.eu/ValueSet/eHDSIProcedure | Procedure |
http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy | Reaction Allergy |
http://terminology.ehdsi.eu/ValueSet/eHDSISeverity | Severity |
http://terminology.ehdsi.eu/ValueSet/eHDSISocialHistory | eHDSI Social History |
http://terminology.ehdsi.eu/ValueSet/eHDSIVaccine | Vaccine |
https://interoperabilidad.minsal.cl/fhir/ig/tei/ValueSet/TipoDeObservacion | Tipo de Observación |
https://interoperabilidad.minsal.cl/fhir/ig/tei/ValueSet/VSServicioRequerido | Servicio Requerido |
https://interoperabilidad.minsal.cl/fhir/ig/tei/ValueSet/VSTerminologiasDiag | TerminologiasDiag |
http://jembi.org/fhir/ValueSet/art-follow-up-status-value-set | Follow Up Status |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-brachytherapy-applicator-type-vs | Brachytherapy Applicator Type Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-brachytherapy-device-type-vs | Brachytherapy Device Type Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-disease-progression-qualifier-vs | Disease Progression Qualifier Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-image-guided-radiotherapy-modality-vs | Image Guided Radiotherapy Modality Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-intrafraction-verification-procedure-vs | Intrafraction Verification Procedure Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-intrafraction-verification-qualifier-vs | Intrafraction Verification Procedure Qualifier Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-category-vs | Radiotherapy Category Code Max Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-free-breathing-motion-mgmt-technique-vs | Radiotherapy Free-Breathing Motion Management Technique Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-isotope-vs | Radiotherapy Isotope Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-reason-for-revision-or-adaptation-vs | Radiotherapy Reason for Revision or Adaptation Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-respiratory-motion-management-vs | Radiotherapy Respiratory Motion Management Value Set |
http://fhir.ehealth.gov.vn/core/ValueSet/snomedCT-additional-dosage-instruction | ValueSet dành cho Các chỉ dẫn dùng thuốc (bổ sung) (SNOMED CT) |
http://fhir.ehealth.gov.vn/core/ValueSet/snomedCT-anatomical-body-structure | ValueSet dành cho Vị trí cơ thể theo giải phẫu học (SNOMED CT) |
http://fhir.ehealth.gov.vn/core/ValueSet/snomedCT-clinical-finding | ValueSet dành cho Các thông tin thăm, khám lâm sàng (SNOMED CT) |
http://fhir.ehealth.gov.vn/core/ValueSet/snomedCT-dosage-administration-route | ValueSet dành cho Đường dùng thuốc (SNOMED CT) |
http://fhir.ehealth.gov.vn/core/ValueSet/vaccine-code | ValueSet dành cho Vaccine Code |
http://fhir.ehealth.gov.vn/core/ValueSet/vn-core-condition-code | ValueSet dành cho Mã bệnh tật |
http://fhir.ehealth.gov.vn/core/ValueSet/vn-core-observation-smokingstatus | ValueSet dành cho Tình trạng hút thuốc lá (SNOMED CT) |
http://fhir.ehealth.gov.vn/core/ValueSet/vn-core-occupation | ValueSet dành cho Thông tin nghề nghiệp |
http://fhir.ehealth.gov.vn/core/ValueSet/vn-medication-code | ValueSet dành cho Mã dược phẩm |
http://fhir.ehealth.gov.vn/core/ValueSet/vn-procedure-code | ValueSet dành cho Mã dịch vụ kỹ thuật |
http://hl7.org/fhir/us/breast-radiology/ValueSet/BreastAssessmentCategoryVS | Breast Assessment Category ValueSet |
http://hl7.org/fhir/us/breast-radiology/ValueSet/CalcificationDistributionVS | CalcificationDistribution ValueSet |
http://hl7.org/fhir/us/breast-radiology/ValueSet/ConsistentWithVS | ConsistentWith ValueSet |
http://hl7.org/fhir/us/breast-radiology/ValueSet/NotPreviouslySeenVS | NotPreviouslySeen ValueSet |
http://hl7.org/fhir/us/breast-radiology/ValueSet/PreviouslyDemonstratedByVS | PreviouslyDemonstratedBy ValueSet |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-InfectPersPrecaution | IVR valueset infectiontransport precaution personnel |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-ZUB | IVR valueset status change |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-actRecovAid | IVR valueset Recovery Aid (.143.11.3) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-actRespiOwner | IVR valueset owner (.143.11.6) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-airway | IVR valueset airway (143.11.2) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-allergy | IVR valueset allergy (.143.11.7) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-ambulanceType | IVR Valueset ambulance type (143.11.28) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-bedding | IVR valueset transport bedding (.143.11.17) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-deathManner | IVR valueset manner of death (.143.11.41) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-diagType | IVR valueset diagnosis type (.143.11.16) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-event | IVR valueset event (.143.11.15) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-eyeForm | IVR valueset eye Form (.143.11.43) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-findingsAirway | IVR valueset findings airway (.143.11.39) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-formation | IVR valueset formation (.143.11.9) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-gcs-augenoeffnung | IVR valueset GCS Augenoeffnung (143.11.34) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-gcsMotoric | IVR valueset GCS motorische Reaktion (.143.11.35) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-gcsVerbal | IVR valueset GCS Verbale Kommunikation(.143.11.36) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-hospitalPriority | IVR valueset priority hospital |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-idSource | IVR valueset identification source (143.11.29) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-intensity | IVR valueset intensity (.143.11.27) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-location | IVR valueset location (.143.11.23) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-locationType | IVR valueset location Type (.143.11.42) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-offender | IVR valueset offender (143.11.24) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-patient | IVR valueset patient |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-personRole | IVR valueset role (.143.11.21) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-preTreatType | IVR valueset pre-treatment type (.143.11.13) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-preTreatment | IVR valueset pre-treatment (.143.11.14) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-pressureMethod | IVR valueset blood pressure method (.143.11.47) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-procAirType | IVR valueset procedure airway type (.143.11.40) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-pulesResult | IVR valueset pulse result (.143.11.49) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-pulseMethod | IVR valueset pulse method (.143.11.48) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-respirationObservation | IVR valueset Observation Respiration (.143.11.22) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-result | IVR valueset result (.143.11.44) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-sex | IVR Valueset sex (.143.11.31) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-size | IVR Valueset size |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-symptom | IVR valueset symptom (.143.11.38) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-teamRole | IVR valueset role team (.143.11.8) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-transDesinfection | IVR valueset unit desinfection |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-urgency-adequate | IVR valueset urgency adequate (143.11.37) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-valTxpe | IVR valueset valuables type (.143.11.33) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-ventilation | IVR valueset ventilation (.143.11.46) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-violenceForm | IVR valueset form of violence (143.11.25) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-violenceResult | IVR valueset result of violence (.143.11.26) |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-woundTreat | IVR valueset wound treatment (.143.11.45) |
http://fhir.ch/ig/ch-ems/ValueSet/yes-no-unknown | Yes/No/Unknown |
http://hl7.eu/fhir/hdr/ValueSet/TNM-M-clinical-category-vs | Clinical M |
http://hl7.eu/fhir/hdr/ValueSet/TNM-M-pathologycal-category-vs | Pathological M |
http://hl7.eu/fhir/hdr/ValueSet/TNM-N-clinical-category-vs | Clinical N |
http://hl7.eu/fhir/hdr/ValueSet/TNM-N-pathological-category-vs | Pathological N |
http://hl7.eu/fhir/hdr/ValueSet/TNM-T-clinical-category-vs | Clinical T |
http://hl7.eu/fhir/hdr/ValueSet/TNM-T-pathological-category-vs | Clinical T |
http://hl7.eu/fhir/hdr/ValueSet/admission-voluntary-status-vs | Encounter Voluntary Status Value Set |
http://hl7.eu/fhir/hdr/ValueSet/allergy-intolerance-substances-eu-hdr | Allergy Intolerance |
http://hl7.eu/fhir/hdr/ValueSet/anthropometric-observation-vs | Anthropometric Observation Value Set |
http://hl7.eu/fhir/hdr/ValueSet/bmi-observation-vs | BMI Observation Value Set |
http://hl7.eu/fhir/hdr/ValueSet/body-height-observation-vs | Body Height Observation Value Set |
http://hl7.eu/fhir/hdr/ValueSet/body-weight-observation-vs | Body Weight Observation Value Set |
http://hl7.eu/fhir/hdr/ValueSet/cancer-stage-grading-vs | Cancer Stage Grading: Snomed CT |
http://hl7.eu/fhir/hdr/ValueSet/cancer-stageGroup-vs | Cancer Stage Group: SNOMED CT |
http://hl7.eu/fhir/hdr/ValueSet/circumference-observation-vs | Circumference Observation Value Set |
http://hl7.eu/fhir/hdr/ValueSet/condition-eu-hdr | Condition Value Set |
http://hl7.eu/fhir/hdr/ValueSet/condition-mandatory-eu-hdr | Mandatory Condition Value Set |
http://hl7.eu/fhir/hdr/ValueSet/functional-assessment-scales-vs | Xpandh Functional Assessment Scales |
http://hl7.eu/fhir/hdr/ValueSet/hdr-encounter-type-eu-hdr | In-patient Encounter Type Value Set |
http://hl7.eu/fhir/hdr/ValueSet/medical-devices-eu-hdr | Medical Devices (SNOMED CT) - Xpandh |
http://hl7.eu/fhir/hdr/ValueSet/poa-indicator-eu-hdr | Condition Present on Admission (POA) Value Set |
http://hl7.eu/fhir/hdr/ValueSet/procedure-snomed-eu-hdr | Procedure codes: Snomed CT |
http://hl7.eu/fhir/hdr/ValueSet/skinfold-thickness-vs | Skinfold Thickness Value Set |
http://hl7.eu/fhir/hdr/ValueSet/treated-problem-eu-hdr | Treatment Class Value Set |
http://hl7.eu/fhir/hdr/ValueSet/vital-signs-observation-vs | Vital Signs Observation Value Set |
https://www.ehealth.fgov.be/standards/fhir/core/ValueSet/be-vs-patient-relationship-type | BeVSPatientRelationshipType |
http://hl7.org/fhir/us/birthdefectreporting/ValueSet/bdr-procedurelist | Newborn Procedure List |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.10--20240802091633 | IPS Allergy or Intolerance Conditions |
http://hl7.org/fhir/ips/ValueSet/allergy-reaction-uv-ips | IPS Allergy Reaction |
http://hl7.org/fhir/uv/ips/ValueSet/target-site-uv-ips | IPS Body Site |
http://hl7.org/uv/ips/fhir/ValueSet/specimen-type | IPS Specimen Type |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.57--20171212192725 | Laterality (qualifier) |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.58--20171212193352 | Topographical modifier (qualifier) |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-condition-uv-ips | IPS Allergy or Intolerance Substances |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.66--20240802105026 | IPS Results Radiology Textual Observations |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.71--20240802094107 | IPS Medications Products |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.73--20240802094107 | IPS Problems |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.76--20240802105320 | IPS Results Specimen Collection Method |
http://moh.gov.rw/fhir/ValueSet/vs-arv-regimen | ARV Regimen |
http://moh.gov.rw/fhir/ValueSet/vs-patient-consent-for-sms-notifications | Patient Consent for SMS Notifications |
http://moh.gov.rw/fhir/ValueSet/vs-patient-pregnant | Patient Pregnant |
http://moh.gov.rw/fhir/ValueSet/vs-reason-arv-regimen-change | Reasons for ARV Regimen Change |
http://moh.gov.rw/fhir/ValueSet/vs-reason-for-assessment | Reason for Assessment or Test Not Performed |
http://moh.gov.rw/fhir/ValueSet/vs-reason-sample-cancelled-or-rejected | Lab Order Reasons For Cancelling/Rejecting Lab Order |
http://moh.gov.rw/fhir/ValueSet/vs-specimen-type | Specimen Type Used In Viral Load testing |
http://moh.gov.rw/fhir/ValueSet/vs-vl-suppression | Viral Load Suppressions Status |
http://fhir.ch/ig/ch-lab-report/ValueSet/ch-lab-bloodgroup-antibody-vs | CH LAB-Report BloodGroup Antibody Result (SNOMED CT coded substances) |
http://fhir.ch/ig/ch-lab-report/ValueSet/ch-lab-bloodgroup-immuno-hematology-vs | CH LAB-Report BloodGroup Immunohematology Tests (SNOMED CT coded procedures) |
http://hl7.org/fhir/us/registry-protocols/ValueSet/AbnormalElectrocardiacAssessment | Abnormal Electrocardiac Assessment |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ArterialAccessSite | Arterial Access Site |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CABG | Coronary artery bypass grafting |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CABGType | Coronary Artery Bypass Graft Type |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacArrest | Cardiac Arrest |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacCTAResults | Cardiac CTA Results |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacCatheter | SNOMED Cardiac Catheters |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacInstabilityType | Cardiac Instability Type |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacValves | Cardiac Valves |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CerebrovascularDisease | Cerebrovascular Disease |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ChestPainSymptomAssessment | Chest Pain Symptom Assessment |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ChronicLungDisease | Chronic Lung Disease |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ConcomitantProceduresPerformedType | Concomitant Procedures Performed Type |
http://hl7.org/fhir/us/registry-protocols/ValueSet/DiabetesMellitus | Diabetes Mellitus |
http://hl7.org/fhir/us/registry-protocols/ValueSet/Dyslipidemia | Dyslipidemia |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ElectrocardiacAbnormalityType | Electrocardiac Abnormality Type |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ElectrocardiacAssessmentMethod | Electrocardiac Assessment Method |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ElectrocardiacAssessmentResults | Electrocardiac Assessment Results |
http://hl7.org/fhir/us/registry-protocols/ValueSet/FamilyPrematureCAD | Family History of Premature CAD |
http://hl7.org/fhir/us/registry-protocols/ValueSet/GraftVesselCABGVessel | Graft Vessel CABG Vessel |
http://hl7.org/fhir/us/registry-protocols/ValueSet/HeartFailure | Heart Failure codes from SNOMED |
http://hl7.org/fhir/us/registry-protocols/ValueSet/HemodialysisOrPeritonealDialysis | hemodialysis or peritoneal dialysis |
http://hl7.org/fhir/us/registry-protocols/ValueSet/Hypertension | Hypertension |
http://hl7.org/fhir/us/registry-protocols/ValueSet/HypothermiaInduced | Induced Hypothermia Codes |
http://hl7.org/fhir/us/registry-protocols/ValueSet/InterventionTypes | Intervention Types |
http://hl7.org/fhir/us/registry-protocols/ValueSet/IntraAndPostEvents | Cath PCI qualified list of Events |
http://hl7.org/fhir/us/registry-protocols/ValueSet/LesionSegmentNumber | Lesion Segment Number |
http://hl7.org/fhir/us/registry-protocols/ValueSet/MyocardialInfarction | Myocardial Infarction |
http://hl7.org/fhir/us/registry-protocols/ValueSet/NewYorkHeartAssociation | New York Heart Association Assessment Scale |
http://hl7.org/fhir/us/registry-protocols/ValueSet/OrganDonor | SNOMED Valueset of Organ Donor codes |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PCIIndications | Percutaneous Coronary Intervention Indication |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PCIOperator | PCI Operator SNOMED codes |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PackedRedBloodCells | Packed Red Blood Ceels |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PercutaneousCoronaryIntervention | PCI |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PeripheralArterialOcclusiveDisease | Peripheral Arterial Occlusive Disease |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PriorCABG | Prior History of Coronary Artery Bypass Graft |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PriorDiagnosticCoronaryAngiographyProcedureResults | Prior Diagnostic Coronary Angiography Procedure Results |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PriorMyocardialInfarction | Prior Myocardial Infarction |
http://hl7.org/fhir/us/registry-protocols/ValueSet/SmokingStatus | Smoking Status |
http://hl7.org/fhir/us/registry-protocols/ValueSet/StentType | CathPCI List of Stent Types |
http://hl7.org/fhir/us/registry-protocols/ValueSet/TIMIFlow | TIMI Flow |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ValvularRegurgitation | Valvular Regurgitation |
http://hl7.org/fhir/us/registry-protocols/ValueSet/VentricularSupport | VentricularSupport |
http://hl7.org/fhir/us/registry-protocols/ValueSet/VentricularSupportDeviceType | Ventricular Support Device Type |
http://hl7.org/fhir/us/registry-protocols/ValueSet/YesNo | Yes or No |
http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-condition | Caveat Condition |
http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-device | Caveat Device |
http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-qualifier-value | Qualifier Value |
http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-type | Type of Caveat |
http://hl7.org/fhir/us/hai/ValueSet/nhsn-pathogen-ranking | NHSNPathogenRanking |
http://hl7.org/fhir/us/cardx-htn/ValueSet/MeasSettingVS | Measurement Setting value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/bodyPositionVS | Body Position value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/bpMeasMethodVS | Blood Pressure Measurement Method value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoordinated value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/exertionPhaseVS | Exertion Phase value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/heartRateMeasDeviceVS | Heart Rate Measurement Device value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/heartRateMeasMethodVS | Heart Rate Measurement Method value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/sleepStatusVS | Sleep Status value set |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/condition-code-sct-tw | SNOMED CT診斷代碼值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/health-professional-sct-tw | SNOMED CT + 臺灣醫事司醫事人員類別值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/medical-department-sct-tw | 對應至 SNOMED CT之就醫科別 + 診療科別值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/medication-path-sct-tw | SNOMED CT + 臺灣健保署給藥途徑值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/serviceRequest-category | 臺灣衛福部資訊處ServiceRequest類型值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/smoking-status-comprehensive-code | SNOMED CT 吸菸狀態綜合評估值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/smoking-status-type-code | SNOMED CT + LOINC 吸菸狀態種類向值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/snomed-pregnancy-status-code | SNOMED CT + HL7 NullFlavor妊娠狀態值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/snomed-sexual-orientation-code | SNOMED CT + HL7 NullFlavor 性傾向值集 |
http://fhir.kl.dk/children/ValueSet/BodyheightSCTobservablesChildren | HøjdeObservationskoderSCT |
http://hl7.org/fhir/uv/radiation-dose-summary/ValueSet/component-radiation-dose-summary-vs | Radiation Dose Summary component type |
http://hl7.org/fhir/uv/radiation-dose-summary/ValueSet/procedure-reported-type-rds-vs | Procedure Reported Type Value Set |
http://hl7.org/fhir/us/mdi/ValueSet/vs-embalmed-example | ValueSet - Embalmed example |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-apgar-timing | APGAR Score Timing |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-birth-attendant-titles | Birth Attendants Titles |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-birth-delivery-occurred | Birth Delivery Occurred |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-delivery-routes | Delivery Routes |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fertility-enhancing-drug-therapy-artificial-insem | Fertility Enhancing Drug Therapy and Artificial Insemination Value Set |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-death-cause-or-condition | Fetal Death Cause or Condition |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-death-time-points | Fetal Death Time Points |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-presentations-max | Fetal Presentations - Max |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-presentations | Fetal Presentations |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-remains-disposition-method | Fetal Remains Disposition Method |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-infections-during-pregnancy-live-birth | Infections During Pregnancy Live Birth |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-newborn-congenital-anomalies | Newborn Congenital Anomalies |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-obstetric-procedure-outcome | Obstetric Procedure Outcome |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-performed-not-performed-planned | Performed NotPerformed Planned |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/AxillaSurgeryVS | Axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationImpactVS | Impact of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationTypeVS | Type of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EducationLevelVS | Education level of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EstrogenStatusVS | Estrogen receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GermlineMutationVS | Germline Mutation ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GradingVS | Grading of tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HER2ReceptorStatusVS | HER2 receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HistologicalTypeVS | Histological type of the tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityNewCancerVS | Laterality of new cancer ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityVS | Laterality of breast cancer ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LocationRadiotherapyVS | The location of radiotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/MenopausalStatusVS | Menopausal status of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/PatientTreatPrefVS | Patient treatment preference ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ProgesteroneStatusVS | Progesterone receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecommendedTreatmentTypeVS | Recommended treatment types ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecurrenceMethodVS | Recurrence method ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationReasonVS | Reasoncode of the re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationTypeVS | Type of re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedTherapyVS | Type of targeted therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TherapyIntentVS | Intent of therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TreatmentTypeVS | Type of treatments ValueSet |
http://hl7.org/fhir/us/qicore/ValueSet/qicore-medication-dose-type | QICore SNOMED CT Dosage Codes |
http://hl7.org/fhir/us/qicore/ValueSet/qicore-observation-body-position | QICore Observation Body Position |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/document-type-vs | Tipo de documento ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/newborn-congenital-anomalies-vs | Tipos de doença congénita ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/newbornriskassessment-vs | Tipos de risco para avaliação de recém-nascidos ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/puerperium-vs | Tipos de outcome de puerpério ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/risco-gravidez-vs | Risco de gravidez ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/tipo-gravidez-vs | Tipo de gravidez ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/tipo-parto-vs | Tipos de parto ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/transport-type-vs | Tipos de transporte de recém-nascido ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/vacinas-infancia-vs | Vacinas ValueSet |
http://hl7.org/fhir/us/core/ValueSet/us-core-condition-code | US Core Condition Codes |
http://hl7.org/fhir/us/core/ValueSet/us-core-goal-description | US Core Goal Codes |
http://hl7.org/fhir/us/core/ValueSet/us-core-procedure-code | US Core Procedure Codes |
http://hl7.org/fhir/us/core/ValueSet/us-core-servicerequest-category | US Core ServiceRequest Category Codes |
http://hl7.org/fhir/us/mihr/ValueSet/hypertensive-disorders-pregnancy-SNOMED | ValueSet – Hypertensive Disorders of Pregnancy SNOMED CT |
http://moh.gov.et/fhir/hiv/ValueSet/active-tb-diagnosis-value-set | Active TB Diagnosis Codes |
http://moh.gov.et/fhir/hiv/ValueSet/arv-adherence-value-set | ARV Adherence |
http://moh.gov.et/fhir/hiv/ValueSet/arv-side-effects-value-set | ARV Side Effects |
http://moh.gov.et/fhir/hiv/ValueSet/arv-treatment-value-set | ARV Drugs |
http://moh.gov.et/fhir/hiv/ValueSet/cervical-cancer-screened-value-set | Cervical Cancer Screened |
http://moh.gov.et/fhir/hiv/ValueSet/disclosure-stage-value-set | Disclosure Stage |
http://moh.gov.et/fhir/hiv/ValueSet/edema-presence-value-set | Edema Codes |
http://moh.gov.et/fhir/hiv/ValueSet/encounter-location-value-set | Encounter Locations |
http://moh.gov.et/fhir/hiv/ValueSet/encounter-type-value-set | Encounter Type |
http://moh.gov.et/fhir/hiv/ValueSet/hiv-prevention-plan-value-set | HIV Prevention Plan |
http://moh.gov.et/fhir/hiv/ValueSet/month-ordinals-value-set | Month Ordinal Codes |
http://moh.gov.et/fhir/hiv/ValueSet/nutritional-status-value-set | Nutritional Status |
http://moh.gov.et/fhir/hiv/ValueSet/oi-value-set | Opportunistic Infections |
http://moh.gov.et/fhir/hiv/ValueSet/partner-case-closure-status-value-set | Partner Case Closure Status |
http://moh.gov.et/fhir/hiv/ValueSet/patient-functional-status-value-set | Patient Functional Status |
http://moh.gov.et/fhir/hiv/ValueSet/plan-for-next-step-value-set | ART Not Started - Plan For Next Step |
http://moh.gov.et/fhir/hiv/ValueSet/presenting-symptoms-value-set | Presenting Symptoms |
http://moh.gov.et/fhir/hiv/ValueSet/reason-for-art-eligibility-value-set | Reasons For ART Eligibility |
http://moh.gov.et/fhir/hiv/ValueSet/reasons-for-poor-arv-adherence-value-set | Reasons For Poor ARV Adherence |
http://moh.gov.et/fhir/hiv/ValueSet/referral-reason-value-set | Referral Reason |
http://moh.gov.et/fhir/hiv/ValueSet/residential-type-value-set | Residential Type |
http://moh.gov.et/fhir/hiv/ValueSet/service-provider-value-set | Service Providers |
http://moh.gov.et/fhir/hiv/ValueSet/target-population-category-value-set | Target Population Category |
http://moh.gov.et/fhir/hiv/ValueSet/tpt-alternate-prophylaxis-type-value-set | Alternate TPT Prophylaxis Type Codes |
http://moh.gov.et/fhir/hiv/ValueSet/tpt-prophylaxis-value-set | TPT Prophylaxis Codes For Medication Requests |
http://moh.gov.et/fhir/hiv/ValueSet/tpt-reason-not-eligibile-value-set | Reason Not Eligible for TPT Codes |
http://moh.gov.et/fhir/hiv/ValueSet/treatment-outcome-value-set | Treatment Outcome Codes |
http://moh.gov.et/fhir/hiv/ValueSet/viral-load-status-value-set | Viral Load Status |
http://jembi.org/fhir/ValueSet/client-key-population-status-value-set | Client Key Population Status Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/close-contact-setting-vs | Close Contact Setting Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid-19-disease-severity-value-set | COVID-19 Disease Severity Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid-19-severity-value-set | COVID-19 Signs and Symptoms Severity Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid-19-snomed-diagnosis-vs | COVID-19 SNOMED CT Diagnosis Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-det-notdet-eq-inc-vs | Detected, Not Detected, Inconclusive Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-det-notdet-vs | Detected, Not-detected value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-eqvs | Positive/Negative Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-ind-vs | COVID19 Positive, Negative, Indeterminate value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-inv-incl-vs | COVID19 Positive, Negative, Invalid, Inconclusive value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-inv-vs | COVID19 Positive Negative Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-susp-inv-vs | COVID19 Positive Negative Suspected Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-vs | Positive, Negative value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-react-nonreact-borderline-inv-value-set | Reactive, Non-reactive, Borderline, Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-react-nonreact-inv-vs | COVID19 Reactive, Non-reactive, Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-react-nonreact-vs | COVID19 Reactive Non-reactive value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-reporting-priority-vs | Reporting Priorities Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-signs-1nd-symptoms-value-set | COVID-19 Signs and Symptoms Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-cardiovascular-condition-value-set | COVID-19 cardiovascular underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-gastrointestinal-hepatic-condition-value-set | COVID-19 gastrointestinal or hepatic underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-immune-condition-value-set | COVID-19 immune underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-immunocompromised-condition-value-set | COVID-19 immunocompromised underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-medical-condition-vs | COVID-19 Underlying Medical Condition Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-metabolic-condition-value-set | COVID-19 metabolic underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-neurolgic-condition-value-set | COVID-19 neurologic underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-renal-condition-value-set | COVID-19 renal underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-respiratory-condition-value-set | COVID-19 respiratory underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-uncategorized-condition-value-set | COVID-19 uncategorized underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid91-underlying-hemoglobinopathy-condition-value-set | COVID-19 hemoglobinopathy underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/det-notdet-equivocal-invalid-vs | Detected, Not-detected, Equivocal, Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/det-notdet-inconclusive-invalid-vs | Detected, Not-detected, Inconclusive, Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/detected-not-detected-value-set | Detected, Not-detected Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/fluAB-SARSCoV2-SARSCoV-value-set | Influenza A, Influenza B, SARS CoV 2, and SARS CoV value set |
http://hl7.org/fhir/us/covid19library/ValueSet/fluAB-SARSCoV2-value-set | Influenza A, Influenza B, and SARS CoV2 value set |
http://hl7.org/fhir/us/covid19library/ValueSet/pregnancy-status-value-set | Pregnancy Status Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/present-absent-unknown-vs | Present, Absent, Unknown Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/reactive-non-reactive-value-set | Reactive - Non-reactive value set |
http://hl7.org/fhir/us/covid19library/ValueSet/smoking-status-value-set | Smoking Status Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/state-codes-vs | State Codes Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/yes-no-vs | Yes/No Value Set |
http://cqframework.org/cpg-example-ckd/ValueSet/ckd-valueset-ckd | Chronic Renal Disease Finding ValueSet |
http://cqframework.org/cpg-example-ckd/ValueSet/ckd-valueset-diabetes | Diabetes Finding Codes ValueSet |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIAdverseEventType | Adverse Event Type |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIAllergenNoDrug | Allergen No Drug |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIBloodGroup | Blood Group |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSICodeProb | Problems |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSICurrentPregnancyStatus | Current Pregnancy Status |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIProcedure | Procedure |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIReactionAllergy | Reaction Allergy |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSISeverity | Severity |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSISocialHistory | eHDSI Social History |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIVaccine | Vaccine |
http://moh.gov.zm/fhir/immunizations/ValueSet/vs-underlying-condition | Underlying Conditions |
http://hl7.org/fhir/us/cimi-labs/ValueSet/abnml-int-numeric-nom-value-set | Abnormal Interpretation Numeric Nominal value set |
http://hl7.org/fhir/us/cimi-labs/ValueSet/abnormal-interpretation-value-set | Abnmormal Interpretation value set |
http://hl7.org/fhir/us/cimi-labs/ValueSet/lab-result-code-value-set | Lab Result Code value set |
http://hl7.org/fhir/us/cimi-labs/ValueSet/null-flavor-value-set | Null Flavor value set |
http://hl7.org/fhir/us/cimi-labs/ValueSet/ordinal-value-code-value-set | Ordinal Value Code value set |
http://hl7.dk/fhir/core/ValueSet/dk-core-SCTBasicObservation | DK Core SNOMED CT Basic Observation |
http://hl7.dk/fhir/core/ValueSet/dk-core-TechniquesSCTCodes | DK TechniquesSCTCodes |
http://hl7.dk/fhir/core/ValueSet/sor-organization-type | DK SOR Organization Type |
http://hl7.se/fhir/ig/base/ValueSet/SEBaseAddressPersonVS | SE ValueSet for official address types |
http://hl7.se/fhir/ig/base/ValueSet/SEBaseSKRYrkeSpecialtyVS | SEBaseSKRYrkeSpecialtyVS |
http://hl7.se/fhir/ig/base/ValueSet/SEBaseSKRYrkeVS | SEBaseSKRYrkeVS |
http://hl7.eu/fhir/ig/pcsp/ValueSet/grade-test-vs | Grade: follow up |
http://hl7.eu/fhir/ig/pcsp/ValueSet/laterality-qualifier-lrub-vs | Laterality Qualifier Value Set |
http://hl7.eu/fhir/ig/pcsp/ValueSet/mcode-body-location-qualifier-vs | Body Location Qualifier Value Set |
http://hl7.eu/fhir/ig/pcsp/ValueSet/mcode-cancer-staging-system-vs | Cancer Staging System Value Set |
http://hl7.eu/fhir/ig/pcsp/ValueSet/morphologicAbnormality-eu-vs | Morphologically abnormal structure |
http://hl7.eu/fhir/ig/pcsp/ValueSet/otherInfos-condition-vs | Other Infors Condition |
http://hl7.eu/fhir/ig/pcsp/ValueSet/relapse-type-vs | Relapse type (Local/Distant/Combined) |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-Gvhd-type-eu-pcsp | Gvhd condition |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-ProstheticProcedureType-eu-pcsp | Prosthetic Surgical Procedure Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-action-eu-pcsp | Surgical Actions |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-affectedOrgan-eu-pcsp | Affected Organs (surgery) |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-amputationProcedureType-eu-pcsp | Amputation Surgical Procedure Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-calcest-eu-pcsp | Calculated|Estimated |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-colostomyProcedureType-eu-pcsp | Colostomy Surgical Procedure Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-fromToPosteriorAnterior-eu-pcsp | Body Location Qualifier Value Set |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-gastrostomyProcedureType-eu-pcsp | Gastrostomy Surgical Procedure Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-hereditary-eu-pcsp | Hereditary Predispositions or Disease |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-isotopes-eu-pcsp | Radiotherapy Isotopes |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-radiotherapyDoseType-eu-pcsp | Radiotherapy Dose Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-radiotherapyType-eu-pcsp | Radiotherapy Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sacrifiedOrgan-eu-pcsp | Sacrified Organs (surgery) |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sct-prophylaxis-cathegory-eu-pcsp | SCT Prophylaxis Cathegory |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sct-prophylaxis-type-eu-pcsp | SCT Prophylaxis Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sct-type-eu-pcsp | Stem Cell Transplantation type |
http://hl7.org/fhir/uv/termchangeset/ValueSet/case-significance-vs | Case Significance Value Set |
http://hl7.org/fhir/uv/termchangeset/ValueSet/defining-relationship-type-vs | Defining Relationship Type Value Set |
http://hl7.org/fhir/uv/termchangeset/ValueSet/description-acceptability-vs | Description Acceptability Value Set |
http://hl7.org/fhir/uv/termchangeset/ValueSet/dialect-vs | Dialect Value Set |
http://hl7.org/fhir/uv/termchangeset/ValueSet/el-profile-set-operator-vs | EL Profile Set Operator Value Set |
http://hl7.org/fhir/ValueSet/animal-breeds | animal breeds |
http://hl7.org/fhir/ValueSet/animal-species | animal species |
http://hl7.org/fhir/ValueSet/barrier | Barrier |
http://hl7.org/fhir/ValueSet/condition-cause | Condition Cause Codes |
http://hl7.org/fhir/ValueSet/condition-course | Condition Course Codes |
http://hl7.org/fhir/ValueSet/condition-predecessor | Condition Predecessor Codes |
http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclass | DataElement SDC Object Class |
http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclassproperty | DataElement SDC Object Class Property |
http://hl7.org/fhir/ValueSet/feeding-device | Feeding Device Codes Value Set |
http://hl7.org/fhir/ValueSet/focal-subject | Focal Subject Codes |
http://hl7.org/fhir/ValueSet/protective-factor | Protective Factor |
http://hl7.org/fhir/ValueSet/specimen-additive-substance | Specimen Additive Substance Codes |
http://fhir.ch/ig/ch-ig/ValueSet/ch-ig-example-sct | CH IG Example SNOMED CT |
http://moh.bw.org/ValueSet/vs-reason-sample-cancelled-or-rejected | Reasons why a lab order was cancelled or rejected |
http://moh.bw.org/ValueSet/vs-service-provider | Service Providers |
http://moh.bw.org/ValueSet/vs-specimen-type | Specimen Type Used In Viral Load testing |
http://hl7.org/fhir/uv/genomics-reporting/ValueSet/genetic-therapeutic-implications-vs | Genetic Therapeutic Implications |
https://hl7chile.cl/fhir/ig/clembarazos/ValueSet/VSCatProc | Value Set sobre la categoría del procedimiento relacionado al tipo de parto. |
https://hl7chile.cl/fhir/ig/clembarazos/ValueSet/VSDrogasBlandasYDurasIPS | Drogas duras y blandas |
https://hl7chile.cl/fhir/ig/clembarazos/ValueSet/VSMedicamentos | Value Set sobre los tipos de medicamentos que consume la paciente |
https://hl7chile.cl/fhir/ig/clembarazos/ValueSet/VSPatologiasIPS | Condición de salud o patologías de la paciente |
https://hl7chile.cl/fhir/ig/clembarazos/ValueSet/VSProcedimientosIPS | Procedimientos médicos que se ha realizado la paciente anteriormente. |
https://hl7chile.cl/fhir/ig/clembarazos/ValueSet/VSRolProfesionalIPS | Rol del profesional |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/bodyLandmarkDescriptionVS | BodyLandmarkDescriptionvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/bodyLocationOrientationVS | BodyLocationOrientationvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/bodyLocationQualifierVS | BodyLocationQualifiervalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/bodySideVS | BodySidevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/clockFacePositionVS | ClockFacePositionValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/courseVS | Coursevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/episodeVS | Episodevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/periwoundConditionVS | ReriwoundConditionvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/presentAbsentVS | PresentAbsentValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/pressureUlcerAssociationVS | PressureUlcerAssociationvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/qualitativeWoundDepthVS | QualitativeWoundDepthvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/recurrenceVS | Recurrencevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/surfaceOrientationVS | SurfaceOrientationvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/trendVS | Trendvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/underlyingAnatomicalStructureVS | UnderlyingAnatomicalStructurevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundAnatomicLocationVS | WoundAnatomicLocationvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundAssessmentInterpretationVS | WoundAssessmentInterpretationvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundBedAppearanceVS | WoundBedAppearanceValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundBedColorVS | Wound Bed Color value set |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundEdgeColorVS | WoundEdgeColorValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundEdgeDescriptionVS | WoundEdgeDescriptionValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundExudateAmountDescriptionVS | WoundExudateAmountDescriptionValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundExudateAppearanceVS | WoundExudateAppearanceValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundExudateColorVS | WoundExudateColorValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundExudateOdorVS | WoundExudateOdorValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundGradationVS | WoundGradationValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundInternalItemOrBodyStructureVisibleVS | WoundInternalItemOrBodyStructureVisiblevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundMeasurementDeviceVS | WoundMeasurementDeviceValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundShapeVS | Wound Shape value set |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundTypeEtiologyVS | WoundTypeEtiologyvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundTypeVS | CIMIWoundTypevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/yesNoVS | YesNoValueSet |
http://hl7.nl/fhir/zorgviewer/ValueSet/ACPTreatmentCodelist | ACP behandelingen waardelijst |
http://hl7.nl/fhir/zorgviewer/ValueSet/ProbleemNaamCodelist | Zorgviewer probleem naam waardelijst |
http://hl7.nl/fhir/zorgviewer/ValueSet/SubjectRoleCodelist | Subject rol (beroepen) waardelijst |
http://hl7.org/fhir/us/reportofilltraveler/ValueSet/InfectiousDiseaseVS | Infectious Disease VS |
https://open-health-manager.github.io/standard-patient-health-record-ig/ValueSet/pcd-sleep-observation-code | Patient contributed data: sleep observation code |
https://open-health-manager.github.io/standard-patient-health-record-ig/ValueSet/pcd-sleep-observation-value | Patient contributed data: sleep stage value |
http://profiles.ihe.net/PCC/RIPT/ValueSet/RIPT.Medical.Necessity.VS | Medical_Necessity_VS |
http://profiles.ihe.net/PCC/RIPT/ValueSet/RIPT.Reason.for.Interfacility.Transport.VS | Reason_for_Interfacility_Transport_VS |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-bp-method | FR Core ValueSet BP measurement method |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-height-body-position | FR Core ValueSet BodyPosition |
http://hl7.org/fhir/uv/saner/ValueSet/AllCOVID19RiskFactors | All COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/COPDCOVID19RiskFactors | COPD COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/COVID19Antibody | COVID-19 Antibody |
http://hl7.org/fhir/uv/saner/ValueSet/COVID19Complications | COVID-19 Complications |
http://hl7.org/fhir/uv/saner/ValueSet/COVID19DXSNOMED | COVID-19 SNOMED |
http://hl7.org/fhir/uv/saner/ValueSet/COVID19Exposures | COVID-19 Exposures |
http://hl7.org/fhir/uv/saner/ValueSet/COVID19Organism | COVID-19 Organism |
http://hl7.org/fhir/uv/saner/ValueSet/CardiovascularCOVID19RiskFactors | Cardiovascular COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/ConfirmedCOVID19Diagnoses | Confirmed COVID-19 Diagnosis Values |
http://hl7.org/fhir/uv/saner/ValueSet/DiabetesCOVID19RiskFactors | Diabetes COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/EventContext | Event Context |
http://hl7.org/fhir/uv/saner/ValueSet/HypertensionCOVID19RiskFactors | Hypertension COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/IsolationPrecautions | COVID-19 Isolation Precautions |
http://hl7.org/fhir/uv/saner/ValueSet/KidneyDiseaseCOVID19RiskFactors | Kidney Disease COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/NegativeResults | COVID-19 Not Detected |
http://hl7.org/fhir/uv/saner/ValueSet/NeoplasticCOVID19RiskFactors | Neoplastic COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/ObesityCOVID19RiskFactors | Obesity COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/PositiveResults | COVID-19 Detected |
http://hl7.org/fhir/uv/saner/ValueSet/PregnancyCOVID19RiskFactors | Pregnancy COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/Remdesivir | Remdesivir |
http://hl7.org/fhir/uv/saner/ValueSet/SickleCellCOVID19RiskFactors | Sickle Cell COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/SuspectedCOVID19Diagnoses | Suspected COVID19 Diagnoses |
http://hl7.org/fhir/uv/saner/ValueSet/SuspectedOrConfirmedCOVID19Diagnoses | Suspected Or Diagnosed COVID-19 |
http://hl7.org/fhir/uv/saner/ValueSet/TobaccoCOVID19RiskFactors | Tobacco COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/VentilatorDevices | Ventilator Devices |
http://hl7.org/fhir/uv/saner/ValueSet/VentilatorProcedures | Ventilator Procedures |
http://smart.who.int/immunizations-measles/ValueSet/ARVDrugs-values | ARV Drugs values |
http://smart.who.int/immunizations-measles/ValueSet/AllVaccineTypes | Vaccine Type ValueSet |
http://smart.who.int/immunizations-measles/ValueSet/Birthweight-values | Birthweight valueset |
http://smart.who.int/immunizations-measles/ValueSet/HIVstatus-values | HIV status values |
http://smart.who.int/immunizations-measles/ValueSet/IMMZ.Z.DE9 | IMMZ.Z.DE9 ValueSet for Measles Vaccines |
http://smart.who.int/immunizations-measles/ValueSet/Immunocompromised-values | Immunocompromised valueset |
http://smart.who.int/immunizations-measles/ValueSet/Negativetestresult-values | Negative Test Results |
http://smart.who.int/immunizations-measles/ValueSet/PositiveTestResult-values | Positive Test Result valuest |
http://smart.who.int/immunizations-measles/ValueSet/VaccineTypes | Measles Vaccine Type ValueSet |
http://smart.who.int/immunizations-measles/ValueSet/pregnancystatus-values | Pregnancy status values |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Advance.Directives.VS | Advance Directives |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Antepartum.Education.VS | Antepartum Education |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Antepartum.Family.History.and.Genetic.Screening.VS | Antepartum Family History and Genetic Screening |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Antepartum.History.of.Infection.VS | Antepartum History of Infection |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Antepartum.History.of.Past.Illness.VS | Antepartum History of Past Illness |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Antepartum.Review.of.Systems.Menstrual.History.VS | Antepartum Review of Systems Menstrual History |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Edema.VS | Edema observation |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Fetal.Movement.VS | Fetal Movement |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Fetal.Presentation.VS | Fetal Presentation |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Presence.In.Urine.VS | Presence In Urine |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Smoking.Status.VS | Smoking Status |
http://fkcfhir.org/fhir/ValueSet/fmc-allergy-code-vs | Fresenius Allergy Code Value Set |
http://fkcfhir.org/fhir/ValueSet/fmc-sexual-orientation-vs | Fresenius Sexual Orientation Value Set |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-aviditaet-snomedct | MII VS Mikrobio Aviditaet [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-eucast-snomedct | MII VS Mikrobio EUCAST [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-kultur-methode-snomedct | MII VS Mikrobio Kultur Methode[SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-mikroskopiemethoden-snomedct | MII VS Mikrobio Mikroskopiemethoden [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-morphologie-snomedct | MII VS Mikrobio Morphologie [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-mre-klasse-snomedct | MII VS Mikrobio MRE Klasse [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-organismen-snomedct | MII VS Mikrobio Organismen [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-positiv-negativ-snomedct | MII VS Mikrobio Positiv Negativ [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-qualitative-labor-ergebnisse-snomedct | MII VS Mikrobio Qualitative Labor Ergebnisse [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-voraussichtliche-empfindlichkeit-snomedct | MII VS Mikrobio Voraussichtliche Empfindlichkeit [SNOMED CT] |
https://fhir.kbv.de/ValueSet/KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Urgency | KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Urgency |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_DPE_Declaration_Type | Art der Erklärung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Implant | Medizinprodukt |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Person_Institution | BAI_ART |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Procedure | Prozedur SNOMEDCT |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Reaction_Allergy | Manifestation |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Runaway_Risk | Weglaufgefährdung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Allergy_Substance | Allergie Substanz |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Communication_Disorder | Kommunikationsstörung |
http://ehealthontario.ca/fhir/ValueSet/delivery-method | DeliveryMethod |
http://ehealthontario.ca/fhir/ValueSet/facet | Facet |
http://ehealthontario.ca/fhir/ValueSet/healthcareservice-categories | HealthcareServiceCategories |
http://ontariohealth.ca/fhir/ValueSet/qualified-expertise-role-type | QualifiedExpertiseRoleType |
http://kl.dk/fhir/common/caresocial/ValueSet/KLComplicationCodesSCT | KLComplicationCodesSCT |
http://kl.dk/fhir/common/caresocial/ValueSet/KLEvaluationTypeCodesSCT | KLEvaluationTypeCodesSCT |
http://kl.dk/fhir/common/caresocial/ValueSet/KLObservationCodes | KLObservationCodes |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundgrund | Wundgrund (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundrand | Wundrand |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundumgebung | Wundumgebung |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundlokalisation | Lokalisation der Wunde (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Schmerzassessmentskalen | Scores für Schmerzen |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundschmerz | Wundbezogener Schmerz (VAS, SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Exsudatmenge | Exsudatmenge (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Exsudatfarbe | Exsudatfarbe (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundart | Wundarten (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/WundVerband | Wundverband (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Ernaehrungsstatus | Ernährungsstatus |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Hilfsmittel | Wundbezogene Hilfsmittel - Auswahl (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Immunstatus | Status Immunsystem (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Bewusstseinslevel_qualitativ | Bewusstseinslevel - qualitativ (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Bewusstseinslevel_quantitativ | Bewusstseinslevel - quantitativ (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/EducationCode | Edukation Code |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Laterality | PosiThera - Laterality |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/ProcedureCategory | Maßnahme - Kategorie |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/allergy-code | Allergie Code |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/contentVerbalAssessment | PosiThera - Inhalte verbaler Angaben |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/LowerLegBodyStructure | Location of Ulcer |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-collection-method-snomed-ct | MII VS Patho Collection Method [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-container-type-snomed-ct | MII VS Patho Container Type [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-media-modality-snomed-ct | MII VS Patho Media Modality [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-problem-list-snomed-ct | MII VS Patho Problem List [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-processing-procedure-snomed-ct | MII VS Patho Processing Procedure [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-service-request-snomed-ct | MII VS Patho Service Request [SNOMED CT] |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Allergy_Substance_SNOMED_CT | Allergie Substanz SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Apgar_Score_Identifier_SNOMED_CT | Apgar Score SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Apgar_Score_Value | Apgar Score Wert |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Body_Weight_Method_SNOMED_CT | Körpergewicht Methode Datenerhebung SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Device_SNOMED_CT | Gerät SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Diagnosis_SNOMED_CT | Diagnose SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Dose_Form_SNOMED_CT | Darreichungsform SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Drug_Therapy_Status_Codes_SNOMED_CT | Medikation Therapie Statuscodes SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Glucose_Concentration_Interpretation | Glukosespiegel Interpretation |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Glucose_Concentration_Method_SNOMED_CT | Glukosespiegel Methode SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Glucose_Concentration_SNOMED_CT | Glukosespiegel SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Head_Circumference_BodySite_SNOMED_CT | Head Circumference BodySite SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Medication_Type | Arzneimittel/Rezeptur |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Nursing_Professions | Pflegefachberufe SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_PRN_Medication_Reason_SNOMED_CT | Bedarfsmedikation Bedingung SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Pain_Scale_SNOMED_CT | Schmerzskala SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Practitioner_Speciality_SNOMED_CT | Behandelnder SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Pregnancy_Status_Method_SNOMED_CT | Schwangerschaftsstatus Methode SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Procedure_Categories_SNOMED_CT | Prozeduren Kategorie SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Procedure_SNOMED_CT | Prozedur SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Reaction_Allergy | Manifestation SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Route_of_Administration_SNOMED_CT | Verabreichungsweg SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Stage_Life | Stage Life SNOMED CT® |
http://ehealthontario.ca/fhir/ValueSet/ppr-qualified-expertise-role-type | QualifiedExpertiseRoleType |
http://ehealthontario.ca/fhir/ValueSet/service-category-eServices | Service Category-eServices |
https://fhir.bfarm.de/ValueSet/HealthAppAge | ValueSet for HealthAppAge |
http://hl7.org/fhir/uv/sdc/ValueSet/species | Questionnaire Context Species |
https://demis.rki.de/fhir/ValueSet/answerSetAcuteHBVD | Anwort akute Infektion aufgrund wessen bei Hepatitis B |
https://demis.rki.de/fhir/ValueSet/answerSetAcuteHCVD | Anwort akute Infektion aufgrund wessen bei Hepatitis C |
https://demis.rki.de/fhir/ValueSet/answerSetCauseDiagnosisMYTD | Anwort Anlass der Diagnose bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetCoinfectionHDVD | Anwort Koinfektion mit Hepatitis B bei Hepatitis D |
https://demis.rki.de/fhir/ValueSet/answerSetConservationCLOD | Antwort zur Art der Lebensmittelkonservierung bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetConsumptionCLOD | Antwort zum Ort des Verzehrs bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetDiagnosisCJKD | Anwort spezielle Form bei Creutzfeldt-Jakob-Krankheit (CJK) |
https://demis.rki.de/fhir/ValueSet/answerSetFoodCLOD | Antwort zum verzehrten Lebensmittel bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetFormBAND | Antwort Milzbrand-Krankheitsform |
https://demis.rki.de/fhir/ValueSet/answerSetFormCDFD | Antwort Clostridioides-difficile-Erkrankung, schwere Verlaufsform-Krankheitsform |
https://demis.rki.de/fhir/ValueSet/answerSetFormCJKD | Antwort Creutzfeldt-Jakob-Krankheit (CJK)-Krankheitsform |
https://demis.rki.de/fhir/ValueSet/answerSetFormCLOD | Antwort Botulismus-Krankheitsform |
https://demis.rki.de/fhir/ValueSet/answerSetFormCORD | Antwort Diphtherie-Krankheitsform |
https://demis.rki.de/fhir/ValueSet/answerSetFormMYBD | Antwort Grund für keine Theraie bei Behandlungsabbruch Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetFormYPSD | Antwort Pest-Krankheitsform |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionAnimalWhereHUSD | Anwort Tierkontakt wo bei Hämolytisch-urämisches Syndrom (HUS) |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionEnvironmentSettingCVDD | Antwort zu Infektionsumfeld bei Coronavirus-Krankheit-2019 (COVID-19) |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionEnvironmentSettingMYTD | Antwort zu Infektionsumfeld bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathCJKD | Antwort zum Infektionsweg bei Creutzfeldt-Jakob-Krankheit (CJK) |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHAVD | Antwort zum verzehrten Lebensmittel bei Hepatitis A |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHBVD | Antwort zum Infektionsweg bei Hepatitis B |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHCVD | Antwort zum Infektionsweg bei Hepatitis C |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHEVD | Antwort zum verzehrten Lebensmittel bei Hepatitis E |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHUSD | Antwort zum Infektionsweg bei Hämolytisch-urämisches Syndrom (HUS) |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathIZVD | Antwort zum Infektionsweg bei Zoonotische Influenza |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathMPXD | Antwort zum Infektionsweg bei Mpox |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathOPXD | Antwort zum Infektionsweg bei Orthopocken, andere |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathWhoHUSD | Antwort für Abfrage nach Person bei der sich mit Hämolytisch-urämisches Syndrom (HUS) infiziert wurde |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalHEVD | Antwort zu Tierkontakt bei Hepatitis E |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalHUSD | Antwort zu Tierkontakt bei Hämolytisch-urämisches Syndrom (HUS) |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalRBVD | Antwort zu Tierkontakt bei Tollwut |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalTTVD | Antwort zu Tierkontakt bei Tollwutexpositionsverdacht |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskCVDD | Antwort zu Risikofaktoren bei Coronavirus-Krankheit-2019 (COVID-19) |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskIZVD | Antwort zu Risikofaktoren bei Zoonotische Influenza |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskJobHEVD | Antwort zu Beruflichen Risiken bei Hepatitis E |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskJobHTVD | Antwort zu Beruflichen Risiken bei Hantavirus-Erkrankung, hämorrhagischer Verlauf |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskNEID | Antwort zu Risikofaktoren bei Meningokokken, invasive Erkrankung |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskOtherHEVD | Antwort zu Sonstiger Kontakt bei Hepatitis E |
https://demis.rki.de/fhir/ValueSet/answerSetLocationLymphNodeSwellingMPXD | Anwort Lokalisation der Lymphknotenschwellung bei Mpox |
https://demis.rki.de/fhir/ValueSet/answerSetLocationMucosalLesionsMPXD | Anwort Lokalisation der Schleimhautläsionen bei Mpox |
https://demis.rki.de/fhir/ValueSet/answerSetLocationSkinLesionsMPXD | Anwort Lokalisation der Hautläsionen bei Mpox |
https://demis.rki.de/fhir/ValueSet/answerSetMajorSiteMYTD | Anwort hauptsächlich betroffenes Organ bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetManufacturingCLOD | Antwort zur Art der Lebensmittelherstellung bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetMethodCDFD | Anwort Nachweismethode Clostridioides-difficile-Erkrankung, schwere Verlaufsform |
https://demis.rki.de/fhir/ValueSet/answerSetMinorSiteMYTD | Anwort weiteres betroffenes Organ bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetPathogenHFAD | Antwort Erreger Hämorrhagisches Fieber |
https://demis.rki.de/fhir/ValueSet/answerSetResultOfPrevTreatmentMYTD | Anwort Ergebnis der Vorbehandlung bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetResultOfTreatmentMYTD | Anwort Behandlungsergebnis bei Tuberkulose |
|